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SUMMARY
White matter damage induced by multiple pathogenic mechanisms following acute 
brain injury was investigated in this thesis. White matter tissue from human head- 
injured patients, experimental animal models of oxidative stress and lipid peroxidation, 
an in vitro model of lipid peroxidation and an in vivo model of focal cerebral ischaemia 
were used to determine cytoskeletal changes in white matter. These models were also 
used to determine if there were interactions between primary pathogenic mediators and 
secondary mechanisms.
Cytoskeletal breakdown in the corpus callosum of head-injured patients and 
alterations in calpain activity
Cytoskeletal proteins are essential for the structural integrity and function of axons. In 
this study, the levels of cytoskeletal proteins were measured by Western blotting in the 
corpus callosum tissue from human post-mortem head-injured and control patients. 
There were significant reductions in the levels of neurofilament protein subunits in the 
corpus callosum of head-injured patients compared to controls. In contrast, there was no 
change in the level of p-tubulin or the microtubule associated protein, tau detected by 
Western blotting between the head-injured and control patients. The accumulation of p- 
amyloid precursor protein (P-APP) in head-injured patients detected by 
immunohistochemistry within myelinated axons suggests that cessation of axonal 
transport had occurred in these patients. Increased protein levels of calpain mediated- 
spectrin breakdown products were detected in the corpus callosum of head-injured 
patients compared to controls. Calpain-mediated spectrin breakdown products were 
also identified within myelinated axons in sections processed for 
immunohistochemistry. This immunostaining correlated with the pattern of axonal 
pathology detected by p-APP accumulation. The data suggests that calpain-mediated 
proteolysis has a direct role in axonal damage after human head injury.
White matter damage following systemic injection of the mitochondrial inhibitor,
3-nitropropionic acid in the rat
An experimental animal model of oxidative stress was induced by systemic injection of
3-nitropropionic acid (3-NPA). Animals received an intraperitoneal injection of 10, 15,
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20 or 30 mg/kg 3-NPA or vehicle and were killed 24 hours later. 3-NPA produced a 
concentration dependent increase in axonal pathology within the striatum reflected by 
the amount of p-APP and SNAP-25 accumulation. Axonal damage was anatomically 
coincident with the neuronal lesion. There was no neuronal or axonal damage in the 
subcortical white matter or cerebral cortex in any of the animals treated with 3-NPA. 
Manganese superoxide dismutase immunoreactivity was present in the vehicle and all 3- 
NPA treated groups. The amount of Mn-SOD cellular staining was concentration 
dependently increased within the striatum supporting a role for oxidative stress in the 
mechanism of 3-NPA toxicity. In contrast to the association observed between p-APP 
accumulation and calpain-mediated spectrin breakdown products in head injured 
patients, the presence of calpain-mediated breakdown products was not associated with 
accumulation of p-APP in this experimental animal model. However, calpain 
immunopositive oligodendrocyte-like cells along the subcortical white matter were 
increased in a concentration dependent manner by 3-NPA. Therefore in this 
experimental model, mitochondrial inhibition may lead to the initiation of oxidative 
stress and calpain activation, which could mediate cytoskeletal breakdown in axons and 
oligodendrocytes suggesting an interaction between at least two pathogenic 
mechanisms.
The lipid peroxidation by-product, 4-hydroxynonenal is toxic to axons and 
oligodendrocytes in vivo and in vitro
Effects of 4-hydroxynonenal in vivo: The cytotoxic lipid peroxidation by-product 4- 
hydroxynonenal (4-HNE), was stereotaxically injected into rats which were sacrificed 
24 hours later. 4-HNE produced widespread axonal pathology in the subcortical white 
matter demonstrated by conventional histology and accumulation of p-APP. Damaged 
axons detected by accumulation of p-APP were observed transversing medially and 
laterally away from the injection site following intracerebral injection of 4-HNE. In 
contrast, in the control animals axonal damage was restricted to an area surrounding the 
injection site. This pattern of pathology did not appear to be mediated by endogenous
4-HNE or calpain activation. The lack of evidence of 4-HNE-Michael adducts and 
calpain-mediated spectrin breakdown products after intracerebral injection of 4-HNE
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suggests that 4-HNE might induce other secondary pathogenic mechanisms that could 
account for the axonal pathology observed distant from the injection site.
Effects of 4-HNE in vitro: Oligodendrocyte cultures were incubated with different 
concentrations of 4-HNE over a period of 1, 2 or 4 hours. Exogenous 4-HNE produced 
time dependent and concentration dependent increase in oligodendrocyte cell death in 
culture. After 4 hours the highest concentration of 4-HNE (50pM), produced 100% 
oligodendrocyte cell death. The antibody to the cytoskeletal protein spectrin, detected 
morphological changes in oligodendrocytes where the perikarya had become shrunken 
and processes fragmented at 10 and 50pM 4-HNE compared to the vehicle or lpM  4- 
HNE. The results from these studies show that exogenous 4-HNE causes changes in 
cytoskeletal proteins in axons and oligodendrocytes.
Production of endogenous 4-HNE in a model of permanent focal cerebral 
ischaemia: Conventional histology demonstrated a characteristic ischaemic lesion 
following 24 hours of permanent focal cerebral ischaemia in the rat. p-APP 
accumulation within myelinated axons was widespread within the ischaemic lesion. 4- 
HNE-Michael adducts were present in neuronal perikarya, axons and glial cells within 
the infarcted region. The distribution of 4-HNE-Michael adducts in axons paralleled p- 
APP accumulation observed in adjacent sections. In the cerebral cortex 4-HNE-Michael 
adducts marked a boundary between ischaemic and normal tissue. This data supports a 
role for endogenous 4-HNE after acute brain injury.
Collectively the data has demonstrated that myelinated axons and oligodendrocytes are 
vulnerable to pathogenic mechanisms following acute brain injury. The diversity of 
toxic mediators that contribute to both neuronal and axonal damage highlights the 
complexity of the pathophysiology after acute brain injury. However, multiple sites of 
action could provide targets for pharmacological manipulation.
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CHAPTER I 
INTRODUCTION
1.1. CENTRAL NERVOUS SYSTEM
Central nervous system (CNS) neurons can be either excitatory or inhibitory, and 
modulate motor, sensory or secretory functions. The neuron appears in a variety of 
shapes and sizes throughout the CNS consisting of four parts: cell body (soma or 
perikaryon); numerous apical dendrites; a long myelinated fibre tract (referred to as the 
axon) and a fibre terminal or synapse (Figure 1.1). Neuronal perikarya are rich in 
organelles, which function to maintain the neuron. Intercommunication between 
neurons occurs via chemical or electrical synapses. Axons are components of white 
matter and it is their myelin sheath that gives it the distinguishable white colour. 
Although the neuronal perikaryon and synapse are important in neuronal function and if 
damaged have deleterious consequences for brain function, they are mainly located 
within grey matter. As the focus of this thesis is mechanisms of white matter damage 
only the cytoarchitecture and function of the axon will be discussed in this introduction.
1.1.1 Myelinated axons in the central nervous system
A single axon extends away from the cell body and is frequently enwrapped in a myelin 
sheath by oligodendrocytes (see 1.1.2.1). Myelin covers axons in segments (intemodes) 
interrupted by nodes of Ranvier. Nodes of Ranvier are regions of bare axolemma where 
ionic exchange takes place. This unique structural arrangement is the basis for saltatory 
conduction and allows the axon to function in an energy-efficient manner (Salzer, 
1997). The speed of the conduction is proportional to the thickness of the axon and its 
myelin sheath. Axons function to transport electrical impulses from the soma to the 
effector cell. Essential proteins are also transported either anterograde (soma to 
terminal) or retrograde (terminal to soma) by either slow (l-3mm/day) or fast 
(400mm/day) axonal transport.
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~no~le o f  ranvier
(Modified from Kandel & Schwartz 1985 and Compston 1993)
Figure 1.1 Central nervous system neuron and surrounding neuroglia cells.
CNS neurons are made o f a cell body that is metabolically active and contains the 
genetic make-up necessary for protein synthesis. Dendrites receive signals from other 
neurons. An axon transmits electrical impulses and transports proteins anterograde and 
retrograde along the axon. The presvnaptic terminal releases electrical or chemical 
signals into the extracellular space. Only about 10% o f the cells in the CNS are neurons 
and are surrounded by non-excitable cells, known as neuroglia. Neuroglia cells have an 
important relationship with neurons helping to maintain and support the function o f the 
neuron. Astrocytes function to repair neurons, oligodendrocytes are responsible for 
myelination o f the axon and microglia are macrophage precursors activated after an 
inflammatory response.
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M I C R O T U B U L E S
Figure 1.2 Axonal structure
The unique cytoarchitecture o f  the axon consists o f microtubules, neurofilaments and 
membrane bound proteins that provide structural stability and allow the transportation 
o f  organelles anterograde or retrograde along the axon.
In the axon, there are two specialised regions, the axoplasm and the axolemma. 
Crosslinkage o f  neurofilaments and microtubules form a cytoskeletal core deep in the 
axoplasm. Adjacent to this region lies the membrane bound network o f  actin binding 
proteins. Microtubules are composed o f a -  or p-tubulin subunits that assemble and 
disassemble providing a dynamic rather than a static framework (Mitchison and 
Kirschener 1984). Tubulin polymers form rows o f  protofilaments where the P-tubulin o f 
one dimer is joined to the a-tubulin o f  the next dimer. Microtubule motility is mediated 
by two families o f proteins: kinesin, involved in fast anterograde transport and dyneins, 
which play a role in slow retrograde transport. Microtubule associated proteins (MAPs), 
help to maintain the dynamic structure and stability o f  microtubules. MAP1A, MAP IB 
and tau are abundant in the axon their function being to bind and stabilise microtubules 
(Binder et a l ,  1985). Neuro filaments are highly abundant in mature axons and are part 
o f the interfilament family. The primary type o f  neurofilament is formed from subunit 
polypeptides collectively called neurofilament triplet proteins. The molecular weight o f 
neurofilament subunits has been estimated by gel electrophoresis to be 200kDa = NF-H,
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neurofilament subunits has been estimated by gel electrophoresis to be 200kDa = NF-H, 
150kDa =NF-M and 68kDa = NF-L. NF-L is an assembly protein in the axonal core 
whereas NF-M and NF-H triplet proteins are crosslinking proteins. NF-M and NF-H are 
heavily phosphorylated and thought to have an important role in regulating 
polymerisation of other interfilaments (Stemberger and Stemberger 1983). It has also 
been proposed that neuro filaments are directly involved in the modulation of the axonal 
calibre. Spectrin is an actin binding protein associated with the cytoplasmic surface of 
the plasma membrane. Spectrin is expressed in both neurons and glia cells either as c l ­
o t  p-spectrin. a-Spectrin in axons is sometimes referred to as fodrin. Spectrin bestows 
mechanical stability on the membrane and links transmembrane proteins to the 
cytoskeleton (Goodman and Zagon 1986). Following acute brain injury, there may be a 
decline in cytoskeletal integrity and thus disruption of axonal transport leading to 
degeneration.
1.1.2 Neuroglia cells
During the last century Virchow (Virchow 1846) recognised a non-nervous interstitial 
substance that separated fibrous nervous tissue from blood vessels and referred to it as 
the neuroglia cells “nerveglue”. It was not until the beginning of this century that the 
neuroglia cells were distinguished and separated. (Cajal 1913; 1916). This classification 
was further verified by the introduction of metallic impregnation and light microscopy. 
Basic dye stains of nuclei distinguished different types of neuroglia cells: astrocytes and 
oligodendrocytes, collectively known as macroglia and microglia. More recently 
ependymal cells have been identified. There are two types of astrocytes, fibrous and 
protoplasmic. The functions of astrocytes include the storage of glycogen for periods of 
decreased aerobic respiration and regulation of ionic and osmotic homeostasis. These 
cells bridge between the vascular system, neurons and themselves and detect 
perturbations in the microenvironment. Microglia act as macrophage precursors and 
become activated after an inflammatory response. Infiltrating blood borne macrophages 
in concert with the resident microglia undergo morphologic and functional changes 
which then migrate to the site of injury where they become fully activated. Ependymal 
cells are of cilia type structure lining the ventricle and spinal cord. Their exact function
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is unknown as yet. The introduction to this thesis will now focus on the importance of 
oligodendrocytes.
1.1.2.1 Oligodendrocytes
Oligodendrocytes were first described by Robertson (Robertson 1899) and several 
decades later, classified by a detailed histological description by Del Rio Hortega (1921, 
1928) who categorised two types of oligodendrocytes according to their position within 
the central nervous system. Oligodendrocytes that are located mainly within white 
matter, in rows between myelinated fibre tracts, are interfascicular and thought to be 
involved in myelination. The other, perineuronal satellite cells, usually appear in 
association with neurons in grey matter and may regulate the local environment for 
growth and maintenance of axons (Ludwin, 1997). Oligodendrocytes are derived in the 
subventricular zone from the neuroectoderm in the late gestational period and migrate 
into the CNS (Goldman, 1992, Levison et al., 1993). The cell migrates, proliferates and 
differentiates into a mature, multi-process cell, with a small dark soma, approximately 
10-20pm in diameter, (Wood and Bunge 1984; Wood and Bunge 1986;) and is more 
chromophillic compared to astrocytes. Oligodendrocytes are the myelin forming cells in 
the CNS and are viewed as the structural elements that provide the electrical insulation 
of axons (Bunge 1962; Bunge et al, 1968). One oligodendrocyte can ensheath up to 50- 
60 axons (Ludwin, 1997).
1.1.2.2 Migration, proliferation and differentiation
Oligodendrocytes are derived from mitotic bipolar precursor cells, known as the 0-2A 
progenitor. 0-2A progenitor cells were first found in cultures of the developing optic 
nerve (Raff, 1989) and other regions of the CNS (Levi et al., 1986; Ingraham and 
McCarthy 1989; Miller et al 1989; Goldman, 1992). Aspects of oligodendrocytes have 
determined by the use of in vitro systems. 0-2A cells migrate, proliferate and 
differentiate in to either oligodendrocytes or type 2 astrocytes, depending on the local 
microenvironment (Levison and Goldman 1993; Miller et al., 1989). However, there is 
still some controversy as to whether type 2 astrocytes exist in vivo (Espiniosa et al., 
1993; Williams and Price 1992; Williams et al., 1995). Migration of 0-2A progenitors 
in vitro resembles migration of progenitors into white and grey matter in vivo 
(Goldman, 1992). Similarities in the proliferation of oligodendrocytes have been
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demonstrated between the in vivo and in vitro situation. Mitogenic factors, such as, 
platelet derived growth factor (PDGF) and basic fibroblast growth factor (bFGF) 
regulate the proliferation of 0-2A progenitors in vivo. Continuous cell division occurs 
in serum free cortical glia cultures and optic nerve preparations in a similar time frame 
to cell proliferation in vivo suggesting that the same growth factors might be responsible 
for proliferation (Raff, 1992). Other growth factors are also thought to be involved in 
the development of 0-2A progenitors into post-mitotic multipolar process bearing 
oligodendrocytes (Komoly 1992). What regulates these growth factors is still unclear, 
although adjacent type-1 astrocytes secreting PDGF in vivo and in vitro, or electrical 
signals from axons have been suggested to control oligodendrocyte development 
(Barres and Raff 1993).
1.2 CLINICAL CONDITIONS OF ACUTE BRAIN INJURY
1.2.1 Stroke
Stroke is the third leading cause of death in the United Kingdom. Approximately, 
500,000 patients (Forbes 1993) are admitted to hospital per annum and approximately 
80% of these patients either die or are left disabled (Bamford et al., 1988). The 
prevalence of stroke means that 1 /5 of acute national health service beds and a quarter 
of long term beds in the UK are occupied by these patients. There are two types of 
stroke, ischaemic and haemorrhagic. Ischaemic stroke can be further subdivided into 
thrombotic and embolic. Haemorrhagic stroke can also be divided into intracranial or 
subarachnoid haemorrhage.
1.2.2 Head injury
Head injury is the leading cause of death from accidents in young adults. Many patients 
who sustain a traumatic brain injury are adolescents or young adults who require care by 
their family for a long time. One family in every 300 has a member with such a 
disability emphasising the social and economic problems associated with this type of 
injury. There are two main types of traumatic brain injury: missile and non-missile 
(blunt) head injury. Missile head injury results from moving or fallen objects impacting 
on the brain. Types of missile brain damage are classified as depressed, penetrating or
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perforating and each type depends on the mass, shape and velocity of the missile. Blunt 
(non-missile) head injury is the more common type of head injury in patients admitted 
to hospital. Over a 15 year period a comprehensive study of 635 fatal head injured 
patients was conducted at the Institute of Neurological Sciences, Glasgow and these 
injuries resulted from road traffic accidents (53%); falls (35%); assaults (5%) and others 
(7%) ( Adams and Graham 1996).
1.3 BRAIN PATHOLOGY AFTER ACUTE BRAIN INJURY
1.3.1 Ischaemic stroke
Ischaemic stroke is the most common form of stroke. Cerebral ischaemia occurs when 
there is a reduction in blood flow to a region of the brain from a major artery. Cerebral 
arteries can be occluded by either the build up of a thrombus or due to the presence of 
an embolus lodged in the artery. Reduction of blood flow reduces the delivery of 
oxygen and consequent energy failure, leads to cell death. Morphological changes 
observed after ischaemia within grey matter comprise necrotic neurons that are 
recognisable by their intensely eosinophilic cytoplasm and their poorly stained nucleus 
with haematoxylin. It was previously believed that white matter pathology was 
secondary to neuronal necrosis (Marcoux et al., 1982). It could be that methods used 
previously to determine grey matter damage are not suitable for assessment of white 
matter pathology after cerebral ischaemia. Grey and white matter differ in many 
respects from one another in terms of their blood supply, rates of glucose utilisation, and 
ionic composition (Hansen 1985; Stys et al., 1990; Ransom et al., 1990; Pantoni and 
Garcia 1997; Kumura et al., 1996; Kuroiwa et al., 1998). However, although they differ 
in their cellular and elemental composition it might be that certain neuropathogenic 
factors leading to damage are similar in both grey and white matter. Although there is 
an overwhelming body of evidence for perikaryal damage in grey matter following 
cerebral ischaemia there is little evidence of white matter damage in the literature. There 
is however, some experimental evidence suggesting that following focal cerebral 
ischaemia in the rat that axons (Yam et al., 1998b) and oligodendrocytes (Pantoni et al.,
1996) are vulnerable within 1 hour post injury.
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1.3.2 Head injury
Brain damage resulting from blunt head injury can arise from a variety of processes 
depending on the severity of the injury. Certain types of brain damage cannot be 
determined using neuroradiological equipment and need to be examined post-mortem 
either macroscopically or with the aid of a light or electron microscope. Striking 
differences in the macroscopic changes are observed between mild, moderate and severe 
head injury. There is increasing awareness that what separates mild, moderate and 
severe head injury is not so much the nature of the lesion but its amount and 
distribution, microscopically. Pathology after blunt head injury is either classified as 
focal and diffuse (Table 1.1) or primary and secondary (Table 1.2).
The introduction of this thesis is interested in white matter damage following acute 
brain injury and therefore I will focus on the characteristics of axonal injury after head 
injury.
Table 1.1 Table 1.2
Focal and Diffuse pathology Primary and Secondary pathology
PRIMARY SECONDARY
Scalp lesions Intracranial
haemorrhages
Skull fractures Ischaemic brain 
damage
Contusions & 
lacerations
Brain swelling
Diffuse axonal 
injury
Secondary damage 
due to raised ICP
Diffuse vascular 
injury
Infection
FOCAL DIFFUSE
Scalp lesions Diffuse axonal 
injury
Skull fractures Ischaemic brain 
damage
Contusions & 
lacerations
Brain swelling
Intracranial
haemorrhages
Diffuse vascular 
injury
Secondary damage 
due to raised ICP
Infection
1.3.2.1 Diffuse axonal injury
Diffuse axonal injury (DAI) is considered to be one of the most important types of 
pathology in patients who sustain a blunt head injury. Diffuse axonal injury is a
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common cause of coma in the absence of any intracranial mass lesion (Graham et al., 
1995; Graham and Gennarelli 1997). In patients who died some time after the initial 
head injury and remained in a vegetative or severely disabled state (McLellan et al., 
1986), DAI was the major type of pathology at post-mortem (Graham and Gennarelli
1997). DAI has previously been described as diffuse degeneration to white matter 
(Strich 1956); shearing injury (Peerless et al., 1967); diffuse white matter shearing 
(Zimmerman et al., 1978); diffuse damage of impact type (Adams et al., 1977) or inner 
cerebral trauma (Grcevic 1982) however the term now universally used is “diffuse 
axonal injury” (Adams et al., 1982; Gennarelli et al., 1982).
1.3.3 Assessment of axonal injury
The levels of DAI pathology in human head injury was originally graded using silver 
impregnation (Adams et al., 1982; Adams et al., 1989) In grade I DAI, there is 
histological evidence of axonal injury in the white matter of the parasagittial white 
matter, corpus callosum and brain stem with the absence of focal lesions. In grade II 
DAI, there is widespread axonal injury and also a focal lesion in the corpus callosum. In 
grade III DAI, there is in addition to the diffuse axonal pathology observed in grades I 
& II macroscopical evidence of focal lesions in one or both the dorso-lateral quadrants 
of the rostral brain stem (Adams et al., 1989). Patients with a longer survival time 
displayed a different pattern of pathology, with the appearance of reactive astrocytes, 
gliosed lesion within which are haemosiderin-containing macrophages (Adams and 
Graham 1989). Some lesions in the corpus callosum and brainstem can be seen 
macroscopically, but the axonal damage can only be recognised microscopically 
(Adams and Graham 1989).
Silver impregnation techniques can only detect axonal damage if the patient survived 
for 15 hours or longer after the injury (Adams et al., 1982). However, in the last 10 
years a new more sensitive technique has been introduced for detecting axonal injury 
using an antibody to beta amyloid precursor protein (p-APP). p-APP, is a 
transmembrane bound protein that is carried along the axon by fast anterograde axonal 
transport (Koo et al., 1990) and will accumulate in disrupted axons. Adjacent sections 
from a group of head-injured patients were stained for either silver impregnation or p-
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APP immunohistochemistry. Silver staining revealed that only 30% of the cases had 
evidence of axonal injury while p-APP immunohistochemistry revealed that 90% of the 
head-injured cases had axonal injury. Therefore this demonstrated approximately a 60% 
difference in the amount of axonal injury observed in the head-injured cases between 
the two stains (Figure 1.3) (Gentleman et al., 1995). The use of p-APP 
immunohistochemistry is a more sensitive marker than silver staining and has made the 
identification of earlier and more subtle changes in axonal injury possible. The late 
introduction of sensitive markers of white matter damage, such as p-APP, may have 
contributed to the underestimated importance of white matter damage following acute 
brain injury.
Evidence of axonal injury in a group of head-injured patients can be detected at 2-3 
hours survival using p-APP immunohistochemistry (Sherriff et al., 1994; McKenzie et 
al., 1996). The amount and distribution of axonal bulbs increased with survival time 
with increased P-APP accumulation being present in patients surviving for as long as 99 
days (Blumbergs et al., 1994). p-APP immunostaining has not only been valuable in 
assessing axonal injury after head injury but has also been demonstrated at the margin 
of an ischaemic lesion in the human brain (Oghami et al., 1992; Suenaga et al., 1994; 
Jendroska et al., 1997). Others have reported p-APP accumulation after focal cerebral 
ischaemia in cat (Yam et al., 1999), rat (Yam et al., 1997; Yam et al., 1998a) and a rat 
model of thromboembolic stroke (Dietrich et al., 1998). Irreversible axonal damage was 
once thought to occur solely at the moment of injury and there was a general consensus 
that axons were primarily vulnerable to mechanical loading (Povlishock and Christman 
1995; Gennarelli 1996). However, it is now recognised that although a proportion of 
axons may become severed at the time of injury, so called primary axotomy, many 
axons undergo secondary or delayed axotomy (Graham and Gennarelli 1997; Maxwell 
et al., 1997). The processes leading to secondary axotomy, during which axons undergo 
a sequence of reactive changes which precedes physical disconnection, is thought to 
occur over a period of 12 hours or longer in humans (Gentleman et al., 1993; Grady et 
al., 1993; Blumbergs et al, 1994; Blumbergs et al., 1995; Christman et al., 1994). 
Another important type of pathology after head injury is ischaemic brain damage. 
Ischaemic damage to axons may also be an important pathological consequence after 
head injury. Approximately 90% of head-injured patients have microscopic evidence of
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ischaemic damage post-mortem (Graham et al., 1978). Although the precise biological 
mechanisms underlying the processes of secondary axotomy are unknown at present, it 
is hypothesised that secondary ischaemic brain damage, excitotoxicity (via non-NMDA 
receptors), an increase in intracellular calcium and oxidative stress may all play an 
interactive role in the breakdown of the axonal cytoskeleton. It is during this period of 
secondary axotomy that recovery might be possible if the damage is reversible.
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Figure 1.3 Comparison of silver staining and P-amyloid precursor protein 
accumulation as a m arker of axonal injury
Adjacent sections from a head-injured patient (5 hours survival) were stained for both 
A) silver and B) p-APP. Silver impregnation did not reveal any morphological changes 
in myelinated axons. However, adjacent sections stained with P-APP illustrated diffuse 
p-APP immunoreactive axonal swellings and bulbs. This clearly demonstrates that p- 
APP is a more sensitive marker o f axonal injury than the classically used silver 
impregnation technique.
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1.4 ANIMAL MODELS OF ACUTE BRAIN INJURY
Animal models have been developed over the years in a quest to try and mimic specific 
features of the clinical situation after acute brain injury. The use of animal models 
allows metabolic, neurochemical and behavioural changes to be detected and 
pathogenic mechanisms to be elucidated. The use of animal models allows 
physiological status, age and sex matching to be tightly controlled which contrasts with 
the complex pathophysiology observed in humans after acute brain injury. Different 
types of models have been developed to try and cover the clinical spectrum of human 
brain pathology. Models not only provide information about primary damage but also 
give us an insight into the mechanisms of secondary damage.
A variety of animal models of stroke have been developed over the years comprising the 
pathology of either focal and global ischaemia. Focal models of ischaemia can be 
induced either permanently or transiently. The most commonly used model of 
permanent focal cerebral ischaemia is the occlusion of the middle cerebral artery 
(MCA). Occlusion of the MCA can be achieved by either electrocoagulation of the 
artery itself (Tamura et al., 1981) or advancement of an intraluminal thread via the 
carotid artery to the origin of the MCA (Longa et al., 1989). Transient cerebral 
ischaemia can be induced either by topical application of the vasoconstrictor peptide, 
endothelin 1 (Macrae et al., 1993; Dawson et al., 1993) or placement and withdrawal of 
an intraluminal thread (Longa et al., 1989) and such models have been developed to 
investigate the effects of reperfusion mimicking the clinical situation where blood flow 
has been restored.
In relation to head injury, a variety of different traumatic brain injury models (TBI) are 
used to mimic different types of injury including: cortical impact model (Dixon et 
al.,1991), fluid percussion model (Lindgren and Rinder 1966; Sullivan et al., 1976), 
stretch model of axonal injury (Gennarelli et al., 1989; Maxwell et al., 1991) and a 
model of subdural haematoma (Miller et al., 1990; Bullock et al., 1991). (For more 
detail about trauma models see review Povlishock et al., 1994 and Maxwell et al.,
1997).
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1.5 PATHOGENIC MECHANISMS OF DAMAGE
There are multiple mechanisms proposed to be responsible for the pathophysiology 
observed in white matter following acute brain injury. The mechanisms described in 
detail below are applicable to both ischaemic stroke and secondary factors involved 
after a head injury.
1.5.1 Calcium
Calcium homeostasis is an important factor in the pathogenesis of cell death following 
acute brain injury. Rapid elevation of intracellular calcium (Ca2+)i can occur due to both 
mechanical injury (Shapria et al., 1989; Fineman et al., 1993) and cerebral ischaemia 
(Choi 1988; Siesjo and Bengtsson, 1989). The intracellular concentration of Ca 
during physiological conditions is less than 0.1 pM, that is several orders of magnitude 
less than the concentration in the extracellular milieu. Therefore, movement of calcium 
is tightly controlled by a number of ionic transporters and exchangers. Under 
pathological conditions, loss of control by these systems leads to derangements of the 
calcium gradient. (Figure 1.4). Lack of adenosine triphosphate (ATP) as a consequence 
of ischaemia contributes to the failure of key enzymes responsible for the 
uptake/exclusion of the Ca2+ ion.
An isolated optic nerve preparation has been developed to investigate ionic changes in 
axons and glia after anoxia without the complicating influence of neuronal synapses 
(Hildebrand and Waxman 1984). Following a 60 minute anoxic period accumulation of 
K+ ions in the axoplasm leads to rapid membrane depolarisation (Ransom and Philbin 
1992; Fern et al., 1994; Leppanen and Stys 1997). The unique architecture of the axon,
I ^
with high densities of Na channels present at the nodes of Ranvier, ~1000pm 
(Waxman 1995) means that slight perturbations in the axolemmal permeability will then 
cause even larger ionic imbalances to occur. The concept that axonal damage is a 
consequence of Ca2+ overload has been studied using this optic nerve preparation (Stys 
et al., 1990; Waxman et al., 1993). There are conflicting views as to whether Ca2+ 
directly induces axonal damage or indirectly as a result of other ionic changes. Almost 
ten years ago addition of voltage operated calcium channel (VOCC) blockers did not 
prevent irreversible injury suggesting that Ca2+ entered the axoplasm via a different
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route. However, upon re-examination of these VOCC blockers protective effects were 
reported (Fern 1995). There are still discrepancies in this theory since VOCC blockers 
also inhibit release of Ca2+ from intercellular stores (Genazzani et al., 1996) and from 
electrophysiology studies there is no convincing evidence that VOCCs are present on 
axons (Stys 1998). There is another proposal that Ca2+ overload occurs downstream as a 
consequence of other ionic changes. Membrane depolarisation reverses the operation of 
the 3Na+/Ca2+ exchanger, leading to a rapid influx of Ca2+ (Siesjo et al., 1989). 
Ultrastructural studies demonstrated that preincubation with lpM  tetradotoxin (TTX), 
10 minutes prior to onset of anoxia, allows complete axonal recovery (Waxman et al.,
I I
1994). This evidence proposes that Na channels are directly coupled to Ca entry and 
is something that requires further investigation. Calcium-mediated injury, although via 
different routes, may be a common pathogenic factor involved in both grey (Choi et al., 
1987; Rothman and Olney 1978; Choi 1988) and white matter damage after brain injury 
(For review see Stys 1998).
Alterations in axolemma permeability have also been implicated in axonal injury after 
TBI. Povlishock and colleagues demonstrated moderate TBI evoked alterations in 
axolemmal permeability to horseradish peroxidase, which is normally excluded from 
the axolemma, such that the peroxidase tracer flooded into injured axons in amounts 
proportional to the severity of injury (Pettus et al., 1994). Thus transient defects in the 
axonal membrane may lead to a disruption of ionic and osmotic homeostatic 
mechanisms and extracellular Ca2f, which is usually rigorously controlled in the intra- 
axonal environment, may accumulate in damaged axons (Povlishock 1993; Pettus et al., 
1994; Povlishock et al., 1997). In mild TBI axonal permeability changes are thought to 
be reversible (Graham 1996). However, in moderate to severe TBI ionic imbalances 
occur so that the axoplasm cannot fully restore ionic and osmotic homeostasis 
contributing to axonal cytoskeletal breakdown. There may be initial abnormalities that 
occur within the first few minutes after injury known as mechanoporation, where small 
pores are created in the lipid bylayer (Gennarelli 1997). These mechanopores are 
thought to allow Ca2+ to leak into the cell down its concentration gradient. 
Electrophysio logical studies have demonstrated transient depolarisation of axons after 
stretch injury in the guinea pig optic nerve (Tomei et al., 1990) Cytochemical evidence
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also supports such Ca2+ influx in the same model (Maxwell et al., 1995) with alterations 
in the membrane pump Ca-ATPase and ecto-Ca-ATPase activity being detected.
Once there is an elevated concentration of axoplasmic calcium it can activate a number 
of deleterious pathways that lead to damage (Figure 1.4). Elevated cytosolic calcium 
contributes to cell death by activating lipases which breakdown membranes, nucleases 
which induce DNA fragmentation and proteases, such as calpains which can cause 
cytoskeletal breakdown. In addition, raised axoplasmic Ca2+ could also interact with 
pathogenic mechanisms such as oxidative stress (see 1.5.3) (Silver and Erecinska 1990).
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Figure 1.4 Calcium entry into the axon
A diagrammatic illustration o f  the sequence o f interrelated events leading to the influx 
o f calcium into the axon. Acute brain injury leads to alterations in axolemma 
permeability disrupting ionic homeostasis and encouraging Ca2+ to flow into the cell 
down its concentration gradient through ion channels located on the membrane. 
Elevated cytosolic calcium will then lead to the activation o f a variety o f  enzymes 
which could contribute to axonal dysfunction and damage (1.5.2).
Abbreviations: My, myelin; ATP, adenosine triphosphate; ER, endoplasmic reticulum.
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1.5.2 Calpains
Calcium activated neutral proteases were first identified in rat brain (Gurof 1964) and 
subsequently renamed “calpains”. There are two specific isoforms, p-calpain and m- 
calpain, constitutively expressed in the mammalian brain. Within neurons, there are 
higher levels of p-calpain in the somatodendritic region and lower levels within 
myelinated axons (Perlmutter et al., 1990) while m-calpain is located mainly in axons 
(Hamakubo et al., 1986) and is thought to be a constituent of myelin (Li and Banik 
1995). Calpains are thought to participate in the turnover of cytoskeletal proteins, 
regulation of kinase activities, transcription and long term potentiation under normal 
physiological conditions. These two isoforms are structurally homologous with a 
catalytic 80kDa subunit and a smaller 30kDa subunit, it still remains to elucidate as to 
whether it stabilises (Yoshizawa et al., 1995) or enhances catalytic activity (Tsuji and 
Imahori 1981). The primary difference between p and m-calpain is the concentration of
Ca required to activate them. p-Calpain requires micromolar while m-calpain requires
2+
millimolar concentrations of calcium to be activated. At the resting cytoplasmic Ca
2_|_
concentration, both forms are inactive and become activated when cytosolic Ca 
increases (see above) after acute brain injury. The highest level of calpains is in the 
cytosol, however, when the enzymes are activated they translocate to the phospholipid 
membrane. Phospholipids reduce the concentration of calcium required to activate 
calpain (Suziki et al., 1995). Under pathological conditions membrane disruption 
increases the amount of phospholipids present in the cytosol thus, enhancing calpains 
local proteolytic effects. Calpain activation following acute brain injury have been 
proposed to play a role in the final common neuropathogenic pathway, affecting 
cytoskeletal proteins, membrane proteins and various regulatory and cell signalling 
proteins (Figure 1.5).
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Figure 1.5 Calpains contribute to degradation of cytoskeletal and cellular 
proteins
Ca-*
i
C A L P A I N S
C Y T O S K E L E T A L  M E M B R A N E  CE L L  
D E G R A D A T I O N  P R O T E I N S  S I G N A L L I N G
Calpain activation and calpain-mediated breakdown of the cytoskeleton has been 
proposed as a mediator of damage in a variety of animal models of stroke and TBI. 
Extensive research has demonstrated cytoskeletal breakdown in a variety of TBI 
models. Neurofilament breakdown (NF-L and NF-H) has been demonstrated in 
neuronal cell bodies after controlled cortical impact (Posmantur et al, 1994) and fluid 
percussion injury (Saatman et al., 1996) in the rat. Breakdown of the microtubule 
protein, p-tubulin was evident in both grey and white matter while dephosphorylated tau 
was increased in the cortex and subcortical white matter underlying a subdural 
haematoma (Fitzpatrick et al., 1997). Increased calpain-mediated spectrin breakdown 
products were also detected in both grey (Kampfl et al., 1996; Saatman et al., 1996) and 
white matter (Saatman et al., 1996; Fitzpatrick et al., 1997) after injury. Neurofilament 
breakdown and calpain activation have been demonstrated within myelinated fibre tracts 
in a rat model of spinal cord injury (Banik et al., 1997a). Protein degradation in grey 
matter (Inzuka et al., 1990; Pettigrew et al., 1996) and the axonal cytoskeleton (Dewar 
and Dawson 1996; Yam et al., 1998) have been reported in models of cerebral 
ischaemia. There was also evidence of increased calpain-mediated spectrin breakdown 
products in animal models of focal cerebral ischaemia (Hong et al., 1994; Bartus et al.,
1995) and global ischaemia (Roberts-Lewis et al., 1994; Bartus et al., 1998). The 
importance of calpain-mediated cytoskeletal breakdown mediating the process of acute 
brain damage is supported by the early appearance after injury of cytoskeletal changes 
and calpain activation in both models of TBI and cerebral ischaemia cytoskeletal
breakdown in grey and white matter with concomitant increase of calpain-mediated 
breakdown products is evident. Thus, calpain-mediated injury may represent a final 
common pathway leading to brain damage, regardless of whether the initial cerebral 
insult is traumatic or ischaemic.
As well as the calpain-mediated breakdown of the cytoskeleton, calpains have been 
proposed to interact with other pathogenic processes. Calpains induce the irreversible 
conversion of xanthine dehydrogenase to xanthine oxidase (Fridovich 1970; McCord 
1985; Sussman and Bulkly 1990). Xanthine oxidase in turn catalyses the oxidation of 
xanthine producing superoxide anion (O2 ) accelerating oxidative stress (Figure 1.6).
Figure 1.6 Calpains irreversibly inhibit xanthine dehydrogenase subsequently 
increasing superoxide anions
XDH
XANTHINE + O,
CALPAINS
XO
o 2-
1.5.3 Oxidative stress
In several chronic degenerative disorders such as, Alzheimer's disease, Huntington’s 
disease and Parkinson’s disease oxidative stress has been implicated as pathogenic 
mechanism involved. Oxidative stress has also been proposed to play a major role in the 
pathogenesis of neuronal cell death following cerebral ischaemia and trauma. Reactive 
oxygen species are unstable and attack critical cellular components essential for ion 
homeostasis, membrane integrity and protein synthesis. Oxidative stress has been 
shown to contribute to neuronal cell body death in grey matter following acute brain 
injury (Watson et al., 1984; Doopenberg et al., 1998; see reviews Flamm et al., 1978; 
Chan 1994; Murphy et al., 1999; Love 1999) however, there is little evidence in the 
literature indicating a role for oxidative stress in white matter damage following acute 
brain injury.
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1.5.3.1 Reactive oxygen species
Within the central nervous system, energy is derived from mitochondrial oxidative 
phosphorylation. Uncoupling of oxidative phosphorylation occurs within minutes after 
the onset of ischaemia. (Siesjo et al, 1981; Rachle 1983). Oxidative phosphorylation 
generates ATP and reduces molecular oxygen to water by the sequential addition of 
four electrons and four hydrogens. This process occurs within the electron transport 
chain. There is evidence to indicate that the ubiqinone-cytochrome b region serves as a 
site of oxygen radical production in the brain under such reducing conditions (Cino and 
Del Maestro 1989).
The brain consumes 1/5 of the body’s total oxygen supply (Siddiqi et al., 1996). This 
coupled with a high lipid content and its relative paucity of antioxidants (Coyle and 
Puttfarcken 1993) in the brain could contribute to the production of reactive oxidative 
species (ROS). ROS can be divided into free radicals; superoxide anion (O2*) and 
hydroxyl radical (OH*) and non-radical oxygen species such as hydrogen peroxide 
(H2O2) and hypochlorous acid. ROS readily donate or extract electrons from other 
molecules evoking cellular damage. Amongst ROS they differ in their potencies (Figure 
1.7). Superoxide anion production is not always detrimental, in fact, phagocytes 
produce superoxide anions to kill certain bacterial strains made by neutrophils 
(Halliwell and Gutterridge 1986).
Figure 1.7 Reactive oxygen species order of reactivity
OH* > H20 2 .> 0 2 > 02
The superoxide anion can act as either a strong reducing or weak oxidising agent 
causing significant tissue damage. However, superoxide is reduced to hydrogen 
peroxide and oxygen by the metalloenzyme family of superoxide dimutases (SOD) 
(Figure 1.8A). There are 3 different types of SOD enzymes, Cu/Zn-SOD present in the 
cytosol, Mn-SOD in the mitochondria and Ec-SOD in the extracellular space (Siesjo et 
al, 1989). Endogenous antioxidants and scavenging enzymes play major a role in the 
intracellular defence against oxygen radical damage. Transgenic mice overexpressing
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these SOD isoforms have demonstrated a protective role against hypoxic ischaemic 
insults (Wei 1989; Rosenbaum et al., 1994; Truelove et al., 1994). Hydrogen peroxide is 
then catalysed to water by a heme protein, catalase, (Figure 1.8B) located in 
peroxisomes and the inner mitochondrial membrane. Hydrogen peroxide can also be 
detoxified by the glutathione system (Schraufstter 1985) which is dependent on the 
maintenance of a sufficient metabolic potential via glucose utilisation. Unlike catalase, 
glutathione peroxidase (GPx) will convert any hydroperoxide and not just hydrogen 
peroxide (Juurlink 1997). GPx is present in the cytosol and mitochondria but not within 
peroxisomes. The glutathione (GSH) redox cycle is a protective system that will 
minimise cell damage from oxidative stress (Figure 1.8C). Loss of antioxidant activity 
due to a deficiency in GSH was directly related to mitochondrial damage in the brain 
(Jain et al, 1991).
Figure 1.8 Role of antioxidants
SOD
A 0 2- *  H20 2 + 0 2
B H20 2 catalase^  2H20 + 0 2
C 2GSH + 2H202 -----► 2H20 + 0 2  + GSSH
Under pathological conditions oxidative phosphorylation fails and energy stores become 
depleted very rapidly leading to an excess production of O2- anions (Siesjo 1978; 
Doopenberg et al., 1998). It is during this period that endogenous antioxidants can 
become saturated or their function compromised.
Hydrogen peroxide acts as a poor oxidising agent as its outer orbital is filled. However, 
unlike superoxide, hydrogen peroxide can diffuse easily across cell membranes.
Catalase and GPx cannot remove excess hydrogen peroxide which then allows
hydrogen peroxide to accumulate in tissues and spontaneously dismutate to the 
hydroxyl radical (Beckman 1994). Hydrogen peroxide can catalyse certain transition 
metals iron or copper to produce an extremely toxic hydroxyl radical (OH*). The 
hydroxyl radical is thought to cause the most extensive cellular damage, with rate
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constants on the order of 109 to 1010 m 'ls '1, they react within 5 molecular radi of their 
production (Dykens 1994).
The production of hydrogen peroxide and the hydroxyl radical is enhanced by the 
availability of transition metal ions. Iron is an excellent catalyst as it can exist in more 
than one valance. The ferrous ion (Fe3+) is the stable form while the ferric ion (Fe2+), is 
capable of transferring electrons and facilitating free radical generation. Iron ions 
catalyse the production of hydrogen peroxide from superoxide and then to the hydroxyl 
radical in the overall Haber-Weiss reaction (Figure 1.9).
Figure 1.9 Haber-Weiss reaction
° 2- +  H 2 ° 2 Fe- ZFe^ O H .  +  O H - + D
The ubiquity of iron within the CNS means that it needs to be tightly controlled in a 
bound or stored form. At physiological pH 7.4, iron is bound to transferrin in plasma or 
stored as soluble ferritin. However, if cerebral pH falls to 5.6 or below as occurs 
following ischaemia (Smith et al., 1986) this will induce the release of free iron (Siesjo 
et al., 1985; Rehncrona et al., 1989; Bralet et al., 1992), increasing catalysation of free 
radicals. This process is also thought to be catalysed by copper ions but their 
distribution within the CNS is unknown. Therefore, the distribution of iron within the 
CNS is important particularly to cells with a high iron content, for example, 
oligodendrocytes.
1.5.3.2 Reactive nitrogen species
Nitric oxide (NO) is a gaseous chemical that exists in the CNS. NO is no more reactive 
than oxygen but its metabolism yields a family of potentially dangerous species 
collectively known as reactive nitrogen species (RNS). NO is generated from nitrogen 
and oxygen catalysed by calcium dependent nitric oxide synthase (NOS) (Moncada et 
al., 1991) (Figure 1.10).
The exact identity of the species generated NO»; NO+ or NO' (Stamler et al., 1992) 
depends on the local redox milieu, pH and temperature (Patel et al., 1999) and the
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production of RNS is accelerated by excess intracellular calcium (see 1.7.1) that occurs 
after acute brain injury (Sato et al., 1993; Tominaga et al., 1993). NO* has an unpaired 
electron and out competes SOD for superoxide (Beckman and Crow 1993) and reacts at 
near diffusion limited rates with superoxide to form the peroxynitrite anion (ONOO-) 
(Beckman et al., 1990; Huie and Padmaya 1993; Squarito and Pyror 1995; Crow and 
Beckman 1996). Peroxynitrite can be protonated to form the potent oxidising agent 
peroxynitrous acid (Beckman and Koppenol 1996) (ONOOH) (Figure 1.11). 
Peroxynitrite formation does not require transition metals and thus oxidative stress can 
continue even without the presence of iron.
Figure 1.10 Synthesis of nitric oxide and reactive nitrogen species
OXIDATIVE STRESS 
<----------- NO* NO+
NO
▲
NOS
tCa2
L-CITRULLINE
L-ARGININE
Diagrammatic representation of production of NO from L-arginine catalysed by calcium 
dependent NOS, either producing NO+ or NO* which is involved in oxidative stress.
Figure 1.11 Generation of peroxynitrite and peroxynitrous acid
H+
.  < -------
NO* + O2 *  ONOO---------- >  ONOOH
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Peroxynitrite attacks cellular components which are critical for respiration and signal 
transduction and which possess tyrosine residues or thiol moieties. Peroxynitrite can 
initiate lipid peroxidation by abstracting hydrogen atoms from polyunsaturated fatty 
acids resulting in nitrated lipids and accelerating the cascade of oxidative stress (Radi et 
al., 1991; Darely-Usmar et al., 1992; Rubbo et al., 1994).
Respiratory enzymes involved in the electron transport chain are altered by 
peroxynitrite thus increasing the production of superoxide anions (Castro et al., 1994; 
Hausladen et al., 1994; Bouton et al., 1997). Peroxynitrite inactivates the active site of 
Mn-SOD (MacMillian and Thompson 1999) but not Cu/Zn SOD (Smith et al., 1992) 
and thus can contribute to mitochondrial dysfunction. There is evidence of peroxynitrite 
mediated necrotic (Zingarelli et al., 1996) and apoptotic (Vaux et al., 1994) cell death. 
Peroxynitrite nitrates tyrosine residues and can be detected by specific monoclonal 
antibodies. Nitrotyrosine residues detected by immunohistochemistry were evident in 
infarcted regions after focal cerebral ischaemia (Fukuyama et al.,1998) and in 
ischaemia-reperfusion injury (Malinski et al., 1993; Kumura et al., 1995). Proteins that 
have been nitrated are more susceptible to proteolysis suggesting that there maybe a link 
between proteolytic enzymes, e.g calpains, and oxidative stress. While ROS and RNS 
can cause direct damage to key proteins and DNA they have another potentially long 
lasting effect on membrane lipid bilayers by initiating lipid peroxidation.
1.5.4 Lipid peroxidation
Lipid peroxidation is a self-propagating process in which hydroxyl radicals and 
peroxynitrite anions readily attack lipid membranes. Membranes rich in polyunsaturated 
fatty acids (PUFAs) are more susceptible to attack by free radicals than mono or 
saturated fatty acids because their double bonds allow easy removal of hydrogen atoms. 
Peroxidation continues by abstracting a methylene hydrogen atom from fatty acid side 
chains leaving behind a C centred radical lipid which combines with oxygen to form a 
peroxyradical (Braughler and Hall 1989a; Braughler and Hall 1989b) (Figure 1.12).
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Figure 1.12 Lipid peroxidation
LIPID-H + RADICAL - >  LIPID + RADICAL-H 
LIPID + 0 2 -------------► LIPID-O2-
Lipid02*"is a peroxyradical which attacks membranes, receptors and enzymes and is 
converted into lipid hydroperoxides by removal of methylene carbons from adjacent 
PUFAs, which are toxic and unstable. Lipid hydroperoxides decompose into more 
stable complex aldehydes that are extremely cytotoxic. (Esterbauer 1991; Halliwell 
1992; Siddiqi et al., 1996; Marskberry 1997). Important PUFAs that yield 
hydroxyalkenels with or without iron ions are omega-6 PUFAs. These include linoleate 
acid; y linoleate acid and arachidonic acid with arachidonic acid yielding the highest 
levels of hydroxyalkenel: 2-hydroperoxynonenal, 4,5-hydroxydecenal and 4-
hydroxynonenal (4-HNE) (Comporti 1985; Comporti 1989) (Figure 1.13).
Figure 1.13 4-hydroxynonenal
OH
C5H, ,-CH-CH=CH-CHO
Aldehdye by-products are themselves cytotoxic and may also prolong the initial free 
radical attack. Unlike free radicals, aldehydes are longer lived and can easily diffuse 
from their site of origin and thus attack both intracellular and extracellular targets.
4-HNE is an electrophilic species that covalently binds to cysteine, histidine and lysine 
residues in amino acids by Michael nucleophilic addition (Firguet et al., 1994). 
Alternatively, it can form pyrolle adducts (Montine et al., 1997a; Mattson 1998) with 
proteins such as, neurofilaments, microtubule associated proteins and glial fibrillary 
acidic protein (Montine et al., 1996a; Mattson et al., 1997).
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1.5.4.1 Cytotoxic effects of 4-hydroxynonenal
4-HNE cytotoxicity has been studied predominantly in vitro in a variety of tissue types. 
4-HNE not only damages cells directly but initiates biochemical changes that could 
produce cellular damage. Endothethial cells exposed to 4-HNE displayed significant 
cytotoxic defects (Karlburber 1997) that may have an important effect on the blood 
brain barrier (BBB). BBB permeability defects could allow an influx of oxygen to brain 
tissue thus escalating production of ROS, which could then lead to brain tissue damage. 
Mitochondrial inhibition by 4-HNE increased superoxide anions in cortical 
synaptosomes (Keller et al., 1997). Topical application of 4-HNE induced relaxation of 
pre-contracted cerebral arteries and this was partially prevented by L-NAME. This 
suggests that 4-HNE might interact with nitric oxide affecting the cerebral vasculature 
(Martinez et al., 1994).
Ion homeostasis is an important factor following acute brain injury and 4-HNE can 
increase intracellular calcium levels indirectly. The Na+K+-ATPase transporter is an 
integral membrane protein and is susceptible to both intra and extracellular 
concentrations of 4-HNE. 4-HNE causes irreversible damage to the transporter (Siems 
et al., 1996) and disruption of the membrane potential causes an influx of Ca2+. A slow 
progressive increase in calcium influx was observed in hippocampal slices within 2 
hours of 4-HNE exposure (Mark et al., 1997). 4-HNE binds to the GLT1 glutamate 
uptake transporter on astrocytes (Springer et al., 1997; Keller et al., 1997; Blanc et al.,
1998). If 4-HNE were present then accumulation of glutamate in the surrounding 
microenvironment would augment secondary excitotoxicity in adjacent more vulnerable 
cells.
Most of the above findings have been characterised in culture in vitro, however, there is 
recent data demonstrating that the lipid peroxidation by-product, 4-HNE is toxic in vivo. 
Intracerebral injection of 4-HNE into the basal forebrain induced perikaryal damage 
(Bruce-Keller et al., 1998). In a model of spinal cord injury an increase in 4-HNE 
immunoreactivity was detected in white matter tracts rostrocaudal from the site of injury 
(Springer et al, 1997). However, there is no evidence available indicating that 4-HNE is 
toxic to cerebral white matter.
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AIMS OF THESIS
Extensive research has demonstrated that the neuronal perikaryon in grey matter is 
vulnerable following acute brain injury. The introduction of this thesis has outlined the 
importance of axons and oligodendrocytes and their vulnerability following acute brain 
injury. There are number of non-receptor mediated mechanisms that have been 
discussed in the introduction that might be involved in the pathogenesis of white matter 
damage. A number of these processes can be either initiated at the point of injury or as a 
consequence of primary injury and work either independently or in interaction with 
other pathogenic processes. A hypothesised scheme is illustrated below (Figure 1.14).
Figure 1.14 Cascade of pathogenic factors involved in axonal damage after acute 
brain injury
ACUTE BRAIN INJURY
DAMAGED AXOLEMMA
IONIC HOMEOSTASIS
ENERGY FAILURE 
^  1
OXIDATIVE STRESSCYTOSOLIC Ca'
RNSROS
PROTEOLYTIC ENZYMES
LIPID PEROXIDATION
CALPAINS
Mr J- Mr Mr ^
CYTOSKELETAL BREAKDOWN MEMBRANE PROTEINS CELL SIGNALLING
1
AXONAL DAMAGE
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T h e  s p e c if ic  a im s  o f  th is  th e s is  w ere:
1. To determine if cytoskeletal proteins associated with the axonal cytoskeleton were 
degraded in the corpus callosum after human head injury.
2. To determine whether calpains were activated in the corpus callosum after human 
head injury.
3. To determine if there were pathological changes in white matter following systemic 
injection of a mitochondrial inhibitor, 3-nitropropionic acid in the rat.
4. To determine if intracerebral injection of 4-hydroxynonenal in the rat was toxic to 
both grey and white matter in vivo.
5. To determine if 4-hydroxynonenal was toxic to oligodendrocyte cultures in vitro.
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CHAPTER II 
METHODS AND MATERIALS
2.1 TISSUE COLLECTION
2.1.1 Human brain tissue
The head-injured patients in this study had been managed by the Department of 
Neurosurgery at the Institute of Neurological Sciences, Glasgow. In each case a full 
autopsy was carried out, during which, 11 anatomical defined regions in each cerebral 
hemisphere were dissected from a 1cm coronal slice of unfixed brain at the level of the 
lateral geniculate bodies. This allowed the selection of multiple samples for freezing in 
isopentane and storing at -80°C until neurochemical analysis (Dewar and Graham
1996). Thereafter the specimen was immerse fixed in 10% formal saline for at least 3 
weeks before dissection, using a previously described protocol (Adams et al., 1980). 
Comprehensive histological studies were carried out at the level parasaggital gyrus 
thereby allowing close correlation between observations deriving from the adjacent 
frozen and paraffin embedded brain slices. Material was acquired to the tissue bank 
according to MRC guidelines and was approved by local hospital ethics committee.
Tissue from the corpus callosUm (Figure 3.1) of all head-injured and controls (Table
3.1) was dissected from frozen blocks of the parasaggital region and homogenised for 
Western blot analysis (see 2.2). Adjacent formalin fixed material was paraffin 
embedded and cut into 8 pm sections for histology and immunohistochemistry (see
2.3.1).
2.2 WESTERN BLOTTING
2.2.1 Tissue homogenisation
Human corpus callosum tissue (see 2.1.1) was homogenised with a Polytron in 10 
volumes of ice-cold HEPES buffer: 5mM HEPES; 0.32M sucrose; pH 8; 5mM 
benzamidine; 2mM p.mercaptoethanol; 3mM EGTA; 0.5mM MgSC^; ImM sodium 
vanadate; O.lmM phenylmethylsulfonyl fluoride; 2pg/ml leupeptin; 5pg/ml pepstatin 
and 2pg/ml aprotinin (modified from Masliah et al., 1990). Homogenates were 
centrifuged for 5 minutes in a bench microfuge (Beckman, microfuge E) and the
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supernatant collected. The supernatant was stored at -20°C for either protein assay or 
gel electrophoresis. Protein content of the supernatant was determined to 1 mg/ml 
according to Lowry et al., 1951, using bovine serum albumin as the standard (Figure
2.1). Standards and tissue samples were prepared simultaneously in a 1:1 mixture of 
2% copper sulphate; potassium sodium tartate; sodium carbonate and Folin’s reagent. 
Absorbance readings from a spectrophotometer (Pharmacia. Ultraspec III) were taken at 
680nm and the protein concentration of tissue samples derived from BSA standards. 
Protein samples were prepared in Laemmli sample buffer; 0.1M Tris HC1 pH8; 0.1% 
bromophenol blue, 5M urea, 5% DTT, 5%SDS (Laemmli 1970).
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Figure 2.1 Bovine serum albumin protein standard curve
Linear regression curve demonstrates that absorbency at 680nm increases in a linear 
manner with increasing BSA (mg/ml) protein concentration. Absorbency values for all 
Western blotting experiments (Chapter III) were then derived from the curve to 
determine the protein concentrations of each sample.
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2.2.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)
Protein samples diluted in Laemmli sample buffer (Laemmli 1970) were firstly boiled 
for 5 minutes to denature proteins, placed on ice and then separated by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Gels were prepared with 
either 12% protogel or 8% gradient gel (see appendix 2) in a sandwich of two glass 
plates (Bio-Rad). The resolving gel was prepared first then topped with a 3% stacking 
gel the gels were polymerised with N,N,N’N ’- tertramethylethlenediamine (TEMED). 
25 pg protein were loaded to each lane in the stacking gel and separated through the gel 
in a water cooled gel tank (Bio-rad) at 12mV overnight in 0.19M glycine, 0.024 M Tris 
base and 10% SDS. Biotinylated and prestained molecular weight standards were 
loaded alongside the protein samples to determine the bands were at the correct 
molecular weight. Proteins were then transferred to nitro-cellulose membranes detection 
(Schleicher and Schuell, 0.45pm) for alkaline phosphates using a water-cooled tank blot 
transfer cell at 80v for 3h in 0.19M glycine, 0.024 M Tris base and 20% methanol.
2.2.3 Coomassie blue staining of gels
Gels were stained with 40%, 10% acetic acid and 0.1% coomassie blue overnight at 
room temperature. The following day the gel was destained in a 40% methanol and 10% 
glacial acetic acid solution and this allowed visualisation of protein bands to confirm 
transfer and equal loading of samples.
2.2.4 Immunoblotting
Blots were incubated in Tris-buffered saline, (TBS) (20mM Tris, HC1 pH7.5, 0.5M 
sodium chloride, 0.2% Tween-20, (TBS-T) containing 3% dried non-fat milk for 2 
hours at room temperature. Blots were washed 3 x 1 0  minutes in TBS-T then incubated 
in primary antibody overnight at 4°C. Dilutions of primary antibodies are shown in 
Table 2.1. Blots were washed for 3 x 10 minutes in TBS-T and incubated with 
biotinylated anti-mouse secondary antibody for monoclonal antibodies (1:250) and 
biotinylated anti-rabbit secondary antibody for polyclonal antibodies (1:250) for 1 hour. 
Blots were washed in TBS-T for 3 x 10 minutes. The blots were re-incubated for 1 hour 
with streptavidin-alkaline phosphatase (1:1500 in TBS-T with 3% dried non-fat milk).
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Immunoreactivity was then visualised using an alkaline phosphatase substrate kit (Bio- 
Rad).
2.3.4 Quantitative analysis of immunoreactivity of blots
The optical density (OD) of protein bands on the developed blots was quantified 
using an MCID image analyser (Imaging Research, Canada). The instrument was 
calibrated using Kodak gelatin filters of known OD (Figure 2.2). Calibration 
allows the relative optical density for protein bands to be calculated.
Increasing protein concentrations, detected by SBAbS2, a polyclonal antibody that 
detects calpain-mediated spectrin breakdown products were measured to confirm 
that with an increase in protein concentration there was an increase in relative 
optical density value (Figure 2.3). From the relative optical density values shown 
in figure 2.3, 25pg of protein was taken as the optimal protein concentration 
(Figure 2.4). For the experiments described in Chapter III 25jig protein was 
loaded for all controls and head-injured patients.
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Primary antibodies Table 2.1
Antibody Company Clone Host Blocking
Serum
IH WB
A2B5 Boehringer
Mannheim
A2B5-105 Mouse Horse 1:100
p-APP Boehringer
Mannheim
22C11 Mouse Horse 1:500*
P-tubulin Sigma JDR.3B8 Mouse Horse 1:750
GalC Boehringer
Mannheim
mGalC Mouse Horse 1:100
GFAP Sigma G-A-5 Mouse Horse 1:4000
4-HNE Calbiochem Rabbit Goat 1:2000*
Mn-SOD Calbiochem Rabbit Goat 1:300
NF68 Sigma NR4 Mouse Horse 1:400 1:1000
NF2.0O Sigma NE14 Mouse Horse 1:2000
NF200 Sigma N52 Mouse Horse 1:400 1:1000
SBAbS2 SKB Rabbit Goat 1:10,000 1:20,000
Spectrin Chemicon Mouse Horse 1:1000
SNAP-25 Serotec SP12 Mouse Horse 1:750
Tau 1 Gift Mouse Horse 1:1000
p calpain Chemicon Mouse Horse 1.1000
*: microwave with citric acid pH6; WB; Western blotting; IH: immunohistochemistry; 
SKB: SmithKline Beecham, SBAbS2 antibody was a gift from SmithKline Beecham 
Tau 1 antibody was a gift from Prof. B.Anderton
Characterisation o f cells in culture: Anti-A2B5 = 0-2A progenitor; Anti-GalC = 
differentiated oligodendrocytes and GFAP = astrocytes. Cytoskeletalproteins: p-APP = 
a fast axonal transport protein; p-tubulin = p-tubulin; 4-HNE =4-HNE modifed proteins; 
NF86 = neurofilament (NF) light subunit (independent of phosphorylation); NF200 
(clone NE14) NF heavy subunit dependent on phosphorylation state; NF200 clone N52 
= NF heavy subunit independent of its phosporylation state; SBAbS2 = calpain- 
mediated spectrin breakdown products; Spectrin = brain spectrin, SNAP-25 = a fast 
axonal transport protein and Tau 1 = dephosphorylated tau. Enzymes: Mn-SOD = 
Manganese superoxide dismutase; p-calpain = inactive and active isoforms
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Figure 2.2 Calibration curve for optical density filters
Before measuring protein band of sample, background of the blot was calibrated 
using Kodak gelatin filters of known optical density. On the x axis 0.0 is the OD 
value for the background of the blot, 0.1 -  0.6 is the increase in OD filters. 
Calibration of the imaging system allows the relative optical density for protein 
bands to be calculated.
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Figure 2.3 Linear regression of protein concentration versus optical density
The panel in A) shows a Western blot o f SBAbS2 immunoreactivity in the corpus 
callosum o f a control patient showing the signal produced with increasing protein 
concentrations. The quantitative data in B) demonstrates increasing protein 
concentrations produces a linear increase in relative optical density.
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Figure 2.4 Optical density values for 25pg protein
The panel in A) shows a Western blot o f SBAbS2 immunoreactivity demonstrating 
repeated loading o f 25pg protein for a control patient. The quantitative data in B) shows 
equivalent relative optical density values all three protein samples loaded. S I, S2, S3 = 
protein sample in triplicate.
36
2.3 IMMUNOHISTOCHEMISTRY
2.3.1 Single label immunohistochemistry on paraffin sections
Tissue sections from rat and human studies were dewaxed in histoclear for 10 minutes 
and dehydrated in 100% alcohol for 10 then 5 minutes. Tissue sections were pretreated 
for 30 minutes in 3% hydrogen peroxide in methanol to block endogenous peroxidase. 
Sections were then rinsed in running tap water for 5 minutes and then washed in 50mM 
phosphate buffer saline (PBS). Sections were then incubated for 1 hour with 10% 
normal serum (Table 2.1) 0.5% bovine serum albumin in PBS to reduce non-specific 
binding. Sections were incubated in primary antibody overnight at 4°C (Table 2.1) then 
washed in PBS 2 x 5  minutes the next day. Sections were then incubated for 1 hour in 
biotinylated secondary antibodies: biotinylated anti-mouse secondary antibody for 
monoclonal antibodies (1:100) and a biotinylated anti-rabbit secondary antibody for 
polyclonal antibodies (1:100) (Table 1). Avidin-biotin complex (ABC) was prepared 1 
hour before use. Following incubation with secondary antibody tissue sections were 
washed 2 x 5  minutes in PBS and then incubated in ABC for 1 hour. Finally sections 
were washed in PBS 2 x 5  minutes then developed using 3’3’ diaminobenzidine 
tetrahydrochloride (DAB) as the chromagen. In all immunohistochemistry protocols, 
negative controls were performed by omitting the primary antibody (Figure 2.5).
2.3.2 Fluorescent labelling
Immunohistochemistry on oligodendrocyte cultures (see 2.7.2) to characterise 0-2A cell 
lineage and the presence of astrocytes was detected using fluorescence. Cells were post­
fixed in 4% paraformaldehyde for 15 minutes. Blocking solution was applied to reduce 
non-specific binding for 1 hour and then incubated with primary antibody (Table 2.1) 
overnight at 4°C. The next day cultures were washed in PBS and incubated for 1 hour 
with fluorescein isothiocynate (FITC) and mounted in an aqueous media with anti­
fading agent.
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Figure 2.5 Immunohistochemistry negative control
The scanned image shows the absence o f immunostaining when the primary antibody 
was omitted. This indicates the specificity o f  primary antibody binding. A negative 
control was included in all immunohistochemical experiments. X400 Magnification
38
2.4 AN EXPERIMENTAL MODEL OF OXIDATIVE 
STRESS
2.4.1 Systemic injection of 3-nitropropionic acid
Male adult Sprague-Dawley rats (Charles River), weighing between 300-320g, were 
individually housed before and after injection of 3-nitropropionic acid (3-NPA). Rats 
(n=4 or 5 per group) were injected intraperitoneally with 10, 15, 20 or 30mg/kg 3-NPA 
dissolved in sterile distilled water (pH 7.4 with 5M NaOH) or vehicle (sterile distilled 
water). Animals were monitored for any unusual behavioural changes, e.g motor 
deficits, over a 24 hour period. Rats were deeply anaesthetised with 5% halothane and 
30% oxygen/70% nitrous oxide and transcardially perfused fixed with 0.9% saline and 
then 4% paraformaldehdye 24 hours after injection. Rats were decapitated the heads 
post-fixed for 24 hours in 4% paraformaldehyde the brains were removed and post fixed 
for a further 48 hours before being processed through a series of dehydrating and 
clearing agents and then paraffin embedded (see 2.4.2). 5pm microtome sections were 
collected onto poly-L-lysine slides for histology1 and immunohistochemistry.
2.4.2 Rat tissue processing I
Fixed rat brains were placed supine in a stainless steel matrix and cut into coronal 
blocks. For the 3-nitropropionic acid study (Chapter IV), blocks were cut rostrocaudally 
through the brain although the region of neuropathological interest was at the level of 
the caudate nucleus. The block was placed in a cassette (Surgipath) and processed 
through a series of dehydrating, clearing and waxing agents (Shandon Citadel 1000 
automatic processor). Cassettes were first placed in 50% absolute alcohol for 30 
minutes then 70% absolute alcohol, 30 minutes; 90% absolute alcohol, 30 minutes; 
100% absolute alcohol twice for 30 minutes and then clear through three separate 
histoclear tanks for 30 minutes each and then 30 minutes in paraffin wax at 60’C and 
finally in a vacuum containing paraffin wax for 1 hour. Blocks were removed from 
cassettes and cooled before cutting. 5 pm microtome sections were collected onto poly- 
L-lysine coated slides for histology and immunohistochemistry.
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2.5 AN EXPERIMENTAL ANIMAL MODEL OF LIPID 
PEROXIDATION
2.5.1 Intracerebral injection of 4-hydroxynonenal, ethanol and 
artificial cerebrospinal fluid
Male Sprague Dawley rats (Harlan Olac, UK) weighing between 290-330g were housed 
together before surgery and individually housed afterwards, throughout the 24 hour 
recovery period. Animals were anaesthetised with 5% halothane and 70% nitrous 
oxide/30% oxygen in a perspex box and placed in a David Kopf stereotaxic frame 
(Clark Electromedical). A stereotaxic face mask was fitted over the snout and 
halothane, (1-2%) was administered for duration of the experiment. An incision was 
made in the scalp and Bregma exposed. A craniotomy was made with a dental drill and 
using a Hamilton syringe 0.5pl 64mM 4-hydroxynonenal (4-HNE), vehicle (ethanol) or 
artificial cerebrospinal fluid (aCSF) was injected into the subcortical white matter. 4- 
HNE, ethanol and aCSF were injected at the stereotaxic co-ordinates (A/P = -0.26mm 
from Bregma, L/M = 2mm and D/V = 3mm) at a rate of O.lpl/min. The needle was left 
in place for 10 minutes before removal to allow diffusion of the injectate away from the 
needle tip. The scalp was sutured and 2mls of sterile saline was given subcutaneously. 
Aureomycin (Cyanamid) was applied topically to the scalp to prevent infection. 
Animals were allowed to recover for a period 24 hours and during this period monitored 
for any gross behavioural changes. Animals were then re-anaesthetised with 5% 
halothane 70% nitrous oxide/30% oxygen in a perspex box and then transcardially 
perfused with 0.9% saline and 4% paraformaldehyde. Rats were decapitated and the 
heads post-fixed in 4% paraformaldehyde, the brains removed and post fixed for a 
further 48 hours before being processed through a series of dehydrating, clearing and 
waxing agents and embedded in paraffin. 5pm microtome sections were collected onto 
poly-L-lysine slides for histology and immunohistochemistry.
2.5.2 Rat tissue processing II
For the 4-hydroxynonenal study (Chapter V), rat brains were cut rostrocaudally, and 
placed in cassettes (Surgipath) and hand processed for paraffin embedding. First blocks 
were placed in 50% absolute alcohol for 3 hours; 70% absolute alcohol, 3 hours; 90% 
absolute alcohol overnight, on the second day cassettes were transferred in to 100% 
absolute alcohol twice for 3 hours and then into a mixture of absolute alcohol and
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xylene for 1 hour, fresh xylene replaces the mixture for 1 hour and then the cassettes 
remained in xylene overnight. On the final day the cassettes were removed from xylene 
and put in paraffin wax for 3 hours and transferred to new paraffin wax for 4 hours. 
Blocks were then embedded and cooled before cutting. 5pm microtome sections were 
collected onto poly-L-lysine coated slides for histology and immunohistochemistry.
2.6 HISTOLOGY
2.6.1 Haematoxylin and eosin staining
Histological analyses were performed on rat paraffin tissue sections. Paraffin sections 
were dewaxed and rehydrated through a series of graded alcohols before washing in 
water. The sections were then placed in haematoxylin for periods of between 1-10 
minutes, washed in water, differentiated in hydrochloric acid/1% methlyated spirits and 
washed thoroughly in water. Following incubation in Scots tap water for 1 minute, 
sections were then stained in eosin for 2-5 minutes, washed in water, dehydrated 
through the alcohols before 5 minutes in histoclear and then mounted onto coverslips 
with DPX.
2.6.2 Cresyl fast violet and luxol fast blue staining
Rat tissue sections were dewaxed in histoclear for 10 minutes and rehydrated in 
absolute alcohol for 2 minutes. Sections were then washed in methylated spirits and 
incubated overnight in luxol fast blue. Sections were washed in running water to remove 
excess stain and then differentiated in lithium carbonate (few dips), re-washed in 
running water and then re-incubated with cresyl fast violet overnight. Following this, 
sections were washed in running water and differentiated in acetic acidified methylated 
spirit. Finally, sections were dehydrated through graded alcohols, cleared in histoclear 
and mounted onto coverslips with DPX.
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2.7 CELL CULTURE
2.7.1 Preparation of mixed glial cultures
All cell culture procedures were carried out under sterile conditions. Postnatal (1-3 
days) Sprague-Dawley rats were killed by intraperitoneal injection of 0.1ml sodium 
pentobarbitone, decapitated and the heads placed in 70% ethanol. Skulls were removed 
using fine sterile foreceps and whole brains placed in Hanks Balanced Salt Solution 
without calcium and magnesium (HBSSw/oCaMg). Cerebral hemispheres were 
separated along the median fissure and the hippocampus and meninges removed with 
the aid of a dissecting microscope using transillumination and placed in fresh 
HBSSw/oCaMg. Culture media was drained and the neopallia finely chopped into 
small cubes. Cells were enzymatically dissociated using 2000U/ml collagenase, 0.25% 
trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) incubated at 37°C (5% 
/C02/95%/C>2) for 20 minutes. Cells were then incubated with soya bean trypsin- 
DNAse inhibitor for a few minutes and then 3 mis of HBSSw/oCaMg was added. Cells 
were then triturated, firstly through a 10ml pipette (lOx); 21G needle (5x) and finally 
through a 23G needle (3x) to obtain a single cell suspension. The cell suspension was 
then centrifuged at 1000 rpm for 7 minutes (Hettich zentrifugen, Universal 16/16R). 
The supernatant was removed carefully and 2-3mls of 20% fetal calf serum in 
Dulbecco’s Modified Eagles Medium (20% FCS-DMEM) was added and triturated 
through a 5ml pipette, a 23G followed by a 25G needle (3 times each). Cell density 
was determined by trypan blue exclusion (2.7.5). Trypan blue is a specific dye that is 
only taken up into the cell if cell membrane integrity has been compromised. A 1:10 
dilution of the cell suspension (lOpl), 20% FCS-DMEM (140pl) and 0.4% trypan blue 
(40pl) was prepared and 40pl of mix pipetted onto a haemocytometer. Cells were 
counted at x400 magnification using an inverted phase contrast microscope (Lecia 
DMIL). Only phase bright cells were counted, and blue stained cells were excluded.
Cells were then plated at 6 x 106 per 75cm3 flask. Culture medium was changed after 4 
days to 10% FCS-DMEM and every 3-4 days thereafter until cells were 80% confluent 
or a maximum of 12 days old. Under these conditions a monolayer of polygonal type 1 
astrocytes bed down while phase bright 0-2A progenitor cells reside on top of this 
layer. The unique properties of mixed glia cells growing together allowed us to obtain
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pure oligodendrocyte cultures. The adhesion of 0 2 -A progenitors to the astrocytic layer 
is weaker than adhesion of the astrocytes to the culture flasks, up to 12 days after initial 
plating.
2.7.2 Preparation of oligodendrocyte cultures
To obtain oligodendrocyte cultures a modified method of McCarthy and De Vellis 
(1980) shaking protocol was used. Mixed culture flasks were shaken on an orbital 
shaker (Forma Scientific, Life Sciences International) at 150 rpm for 90 minutes, this 
allowed removal of unwanted debris and microglia. The cultures were then re-incubated 
with fresh 10% FCS-DMEM for 1 hour. Cultured flasks were then re-shaken at 260rpm 
for 18-22 hours, this allowed detachment of 0-2A progenitors. The media collected 
from the shaken flasks was poured through a 10pm mesh which had been soaked with 
70% ethanol. Residual cells were obtained from flasks rinsed with a small volume of 
unsupplemented DMEM. Sieved media was then centrifuged at 2000rpm for 10 minutes 
and the supernatant discarded. Sato’s media (1-2 mis) was added to the pellet prior to 
trituration (23G then 21G needle). Cell density was determined by trypan exclusion as
described for mixed glia cells (see 2.7.1). Cells were plated at 2 x 10^ on poly-L-lysine 
coverslips. Cultures were incubated (37°C (5% /C02/95%/C>2) for 7 days being fed 
every 2 days with fresh Sato’s media. Seven day old oligodendrocytes were then 
treated with different toxins thought to play a biological role in oxidative stress (see 
2.7.4; 2.7.5).
2.7.3 Characterisation of 0-2A cell lineage
The sequential process and changes in phenotype during maturation and differentiation 
of 0-2A cell lineage can be labelled by immunohistochemistry. Using specific 
antibodies that recognise cell surface antigens at different stages of oligodendrocyte 
development (Figure 2.8). Anti-A2B5 detects the initial proliferating bipolar cell that 
can then be differentiated into either an oligodendrocyte or type-2 astrocyte. 
Oligodendrocytes immunolabelled with anti-galactocerebroside while type-2 astrocytes 
are detected by anitbodies against glial fibrial acidic protein (GFAP).
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Figure 2.6 Immunodetection of 0-2A progenitors and their differentiation into 
either type-2 astrocytes or oligodendrocytes in vitro
Representative photographs o f  A) 0 -2A  progenitors visualised by A2B5 antibody (2 
days in culture) B) GFAP positive type 2-astrocyte (7 days in culture) C) 
oligodendrocyte labelled with the galactocerebroside antibody (7 day in culture) and 
D) omission o f primary antibody. 0 -2A  progenitors can divide into either 
oligodendrocytes or type-2 astrocytes depending on the culture media. Magnification 
X400
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2.7.4 Glucose/glucose oxidase treatment
Following characterisation o f cultures, the first study was to evaluate an experimental 
paradigm which has been previously reported to detect oligodendrocyte cell death using 
similar oligodendrocyte cultures (Kim and Kim 1991). Oligodendrocyte cultures were 
taken at 7 days and were first washed in minimum Eagles medium (MEM) for 2 x 5 
minutes, then incubated in MEM + 0.5% glucose for 30 minutes at 37°C (5% /C02 
95%/02). 20mU/ml glucose/glucose oxidase was dissolved in 0.05M sodium acetate 
buffer pH 5.1 and added to cultures for 1, 2 or 4 hours (Kim and Kim 1991). This 
particular experiment was chosen because incubation with glucose/glucose oxidase 
enzymatically generates a free radical system. Glucose oxidase in a glucose 
environment produces hydrogen peroxide directly at a slow continuous rate (Rubin and 
Faber 1984) (Figure 2.7). Control cultures contained MEM + 0.5% glucose for each 
time point. Cell viability was assessed using trypan blue and cell death calculated (see 
2.7.5).
* * *
Vehicle 1 2 4
( n= 3 ) ( n = 3) ( n = 3) ( n = 3)
Time (hours)
Figure 2.6 Glucose/glucose oxidase kills oligodendrocytes in a time dependent 
manner
20mU/ml glucose oxidase plus 0.5% glucose time dependently increased 
oligodendrocyte cell death over 1, 2 and 4 hours. There was a significant increase in the 
percentage o f oligodendrocyte cell death following 2 and 4 hours. Data are mean + 
SEM. One way ANOVA post tested with Student’s t test and corrected with Bonferroni. 
The data replicate the findings by Kim and Kim 1991. Vehicle = MEM +0.5% glucose 
at the longest time point, 4 hours.
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2.7.5 Calculating percentage of oligodendrocyte cell death
Oligodendrocytes cultures grown on coverslips were treated with various toxins after 
seven days in culture and the cell viability determined by trypan blue exclusion. At the 
end of the experiment, cultures were incubated in a 1:1 mix of 0.4% trypan blue: HBSS 
for 10 minutes then washed in phosphate buffered saline (PBS) for 2 x 2 minutes and 
then post fixed with 3% glutaraldehyde in 0.1 M phosphate buffer for 1 hour. Coverslips 
were then mounted in an aqueous mounting media; (8g polyvinyl alcohol, 0.2M Tris- 
HC1 pH8.5, 20ml glycerol and 1-2.5% 1,4 diazoabicyclo(2,2,2) octane). To ascertain 
cell viability a 1cm square graticule was placed in 10 randomly selected areas in each 
coverslip. The number of dead, trypan blue positive, and number of live, phase bright 
cells, were counted using a phase contrast microscope (Lecia) at X200 magnification. 
The percentage cell viability was expressed as the number of dead cells (Cd) minus the 
number of live cells (Cl) divided by the total number of cells (Ct) (Figure 2.7).
Figure 2.8 Calculating percentage of oligodendrocyte cell death
% cell death — C q — C l
C t
2.7.6 4-Hydroxynonenal treatment
Seven day old oligodendrocyte cultures were washed with Sato’s for 2 x 5 minutes and 
then incubated at 37°C (5%/C02 95%/Oi) with 1, 10 or 50pM 4-hydroxynonenal or 
vehicle (0.2% ethanol) for 1, 2 or 4 hours. 4-HNE concentrations (1-50juM) are within 
the range known to be generated in cells exposed to FeSC>4 and other insults that induce 
membrane lipid peroxidation (Esterbauer et al 1991; Mark et al 1997). Trypan blue 
exclusion assessed cell viability as described for glucose/glucose oxidase (see 2.1.6). 
Morphological changes of cultured oligodendrocytes was also assessed as an endpoint 
and assessed using immunohistochemistical labelling of a monoclonal antibody against 
the cytoskeletal protein, spectrin (see 5.3.2).
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CHAPTER HI
CYTOSKELETAL BREAKDOWN IN THE CORPUS CALLOSUM OF 
HEAD-INJURED PATIENTS AND ALTERATIONS IN CALPAIN
ACTIVITY
3.1 INTRODUCTION
Diffuse axonal injury (DAI) is an important type of pathology in patients who sustain a 
blunt head injury, being the commonest cause of coma in the absence of an intracranial 
mass lesion (Graham et al., 1995; Graham and Gennarelli 1997). Irreversible axonal 
damage was once thought to occur solely at the moment of injury and there is general 
consensus that axons are primarily vulnerable to mechanical loading (Povlishock and 
Christman 1995; Gennarelli 1997). However, it is now recognised that although a 
proportion of axons may become severed at the time of injury, so called primary 
axotomy, many axons undergo secondary or delayed axotomy (Graham and Gennarelli 
1997; Maxwell et al., 1997). The processes leading to secondary axotomy, during which 
axons undergo a sequence of reactive changes which precedes physical disconnection, is 
thought to occur over a period of 12 hours or longer in humans (Gentleman et al., 1993; 
Grady et al., 1993; Blumbergs et al, 1994; Blumbergs et al., 1995; Christman et al., 
1994) indicating a potential window of opportunity for therapeutic intervention. In order 
to exploit this it is essential to determine the pathogenic mechanisms, which lead to 
axonal damage after head injury.
Disruption of ionic homeostasis with a concomitant increase in (Ca2+)i occurs after 
acute brain injury (Choi 1988; Siesjo and Bengtsson 1989; Shapira et al., 1989; 
Fineman et al., 1993). Raised (Ca2+)i can activate the neutral proteases p and m-calpain 
the substrates for these enzymes being cytoskeletal proteins essential for axonal 
structure and function. In grey matter after experimental traumatic brain injury (TBI) in 
the rat, a loss of cytoskeletal proteins was detected after injury (Posmantur et al., 1994; 
Saatman et al., 1996; Fitzpatrick et al., 1997) and cytoskeletal changes were also 
observed after focal ischaemia (Inuzuka et al., 1990; Dewar and Dawson 1996). 
Evidence of calpain activation by an increased amount of calpain-mediated spectrin 
breakdown products in neurons were also evident in experimental models of TBI 
(Kampfl et al., 1996), focal ischaemia (Bartus et al., 1995) or global ischaemia 
(Roberts-Lewis et al., 1994; Bartus et al., 1998). There is also evidence of these 
breakdown products in myelinated fibre tracts in the rat after experimental TBI 
(Saatman et al., 1996; Newcomb et al., 1997; Fitzpatrick et al., 1997). Thus, calpain- 
mediated breakdown may represent a final common pathway leading to 
neurodegeneration, regardless of whether the initial cerebral insult is traumatic or
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ischaemic. However, although there is compelling evidence for this pathogenic 
mechanism in experimental animal models, evidence that these events occur in human 
head injury is currently lacking.
3.2 AIM
Therefore the aim of this study was to determine cytoskeletal protein integrity and 
alterations in calpain activity in the corpus callosum from post-mortem brains from 
patients who died following a blunt head injury.
3.3 MATERIALS AND METHODS
Fresh brain tissue was obtained post-mortem from 10 patients (6 males; 4 females) who 
died following a head injury and 6 control patients (3 males; 3 females) who died of 
causes other than head injury' and who had no other CNS pathology (Table 3.2). Tissue 
of the corpus callosum was dissected out from frozen parasaggital blocks (Figure 3.2). 
The survival times after injury in the head-injured group ranged from 4h to 12.5 days 
(Table 3.3). There were no significant differences between head-injured patients and 
controls for age or post-mortem delay (Table 3.1) (time between death of the patient and 
freezing of the tissue). There were no clinical or neuropathological criteria applied to 
the inclusion or exclusion of the head-injured cases for this study.
Table 3.1 Statistical data for age and post-mortem delay
Head-injured Control
Age 47.7 ±5.6 59.1 ±3.1
Post-mortem 57 ±6.7 49 ± 4.6
delay
Data are mean ± SEM.
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Fresh frozen corpus callosum tissue was homogenised (see 2.2.1) and protein content 
determined (Lowry 1970). 25pg of protein were separated by SDS-PAGE and detected 
by Western blotting (2.2). Gels were: 10% for p-calpain; 12.5% for tau, NF68,
P-tubulin, (both Protogel, National Diagnostics). Gradient gels were 8% for NF200 
and calpain-mediated spectrin breakdown products, detected by SBSbS2 (Prosieve, 
Flowgen) (see appendix). Biotinylated and prestained molecular weight standards (Bio- 
Rad) were loaded alongside the protein samples, transferred and detected, to ensure 
proteins bands detected were at the correct molecular weight. Optical density of protein 
bands were measured (see 2.2.4). Data are presented as mean ± standard error of the 
mean (SEM) for control and head-injured groups. Significant differences between head- 
injured patients and controls were determined by unpaired, two-tailed Students t test.
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corpus callosum
Figure 3.1 Coronal brain slice of a human head-injured patient
Formalin-fixed coronal brain slice o f  a human head-injured patient. The dotted line 
illustrates the parasagittal block from which the corpus callosum was dissected from the 
frozen samples. The arrow indicates the corpus callosum, a white matter commissure, 
where axonal damage is frequently observed following head injury in man (Adams et 
al., 1989; McKenzie et al., 1996). This head-injured case shows evidence o f a 
contusion within the corpus callosum, the area o f  neuropathological interest. The 
dissected tissue was homogenised and stored at -20°C prior to Western blotting.
3.3.1 Assessment of axonal damage
To determine if there was axonal damage in the corpus callosum, sections were cut from 
the formalin-fixed, paraffin-embedded blocks adjacent to the fresh-frozen blocks. 
Sections o f  corpus callosum from all head-injured patients and controls were processed 
for amyloid precursor protein ((3-APP) immunostaining as described previously 
(Gentleman et al., 1995). The amount and distribution o f (3-APP immunoreactivity was
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then graded and given a score rating on a scale of 0-3, as described previously 
(Gentleman et al., 1995) (Table 3.2). The amount and distribution of hypoxic brain 
damage was also assessed: it was severe when the lesions were diffuse, mutli-focal or 
large infarcts in the distributions of arterial territories, and moderate when lesions were 
limited to the arterial boundary zones, singly or combination with sub-total infarction in 
the distribution of the cerebral arteries (Graham et al., 1989). The ability to attribute P- 
APP immunoreactive axons to either DAI or in association with infarction is based on 
interpretation of the different patterns of immunoreactivity. These findings when taken 
in conjunction with the more widely based neurohistological assessment in man and 
allowed the p-APP immunoreactivity to be interpreted as being due either to DAI or to 
other types of axonal injury associated infarction often in association with internal 
herniation. This part of the work was carried out by Professor D.I. Graham, 
neuropathologist at the Southern General Hospital, Glasgow. p-APP immunostained 
sections were graded by E. McCracken.
Adjacent sections of corpus callosum from all head-injured and control cases were 
immunostained for calpain-mediated spectrin breakdown products, detected by 
polyclonal antibody SBAbS2. SBAbS2 detects spectrin eptiopes specifically cleaved by 
p/m calpain. SBAbS2 stained sections were also analysed and given a score 
according to the amount and distribution of immunostaining as above.
3.4 RESULTS
3.4.1 Cytoskeletal proteins
In the corpus callosum of the head-injured patients there was a marked reduction 
in the levels of NF200 protein immunoreactivity compared to controls. Using 
clone NE14, the antibody which detects only phosphorylated NF200, there was an 
approximately 80% reduction in immunoreactivity in the head-injured patients, 
compared to the controls (Figure 3.2). In the case of the N52 antibody, which 
detects NF200 independent of the phosphorylation state of the protein, there was a 
40% reduction in immunoreactivity in the head-injured patients compared to the 
controls (Figure 3.3). In addition to these marked changes in NF200 levels in the 
head-injured cases there was also a significant reduction in NF68
53
immunoreactivity in the corpus callosum of the head-injured patients compared to 
the controls, NF68 immunoreactivity in the head-injured patients being reduced 
by 50% (Figure 3.4). Thus, in the head-injured patients there was a marked 
degradation of both high and low molecular weight neurofilament triplet proteins 
in the corpus callosum. In contrast, microtubule associated proteins were not as 
prominently affected compared to neurofilament triplet proteins in the head- 
injured patients. P-tubulin immunoreactivity was not significantly different 
between the head-injured patients and the controls (Figure 3.5). Tau 1, a 
monoclonal antibody which only recognises a non-phosphorylated epitope within 
tau, demonstrated a modest reduction of immunoreactivity to dephosphorylated 
tau in the head-injured group compared to the controls (Figure 3.6), although the 
difference was not statistically significant.
3.4.2 Calpain
Both 80- and 76kDa forms of the p-calpain were detected in the corpus callosum 
of both controls and head-injured patients (Figure 3.7). The 80kDa form of p- 
calpain is thought to reflect the inactive form of the enzyme while the 76kDa form 
reflects the active component (Kishimoto et al., 1989). In the head-injured 
patients, there was a significant reduction in the levels of the 80kDa form of p- 
calpain compared to the controls while there was no difference between the two 
groups in the 76kDa form (Figure 3.7). The ratios of 76:80kDa forms between the 
head-injured (1.5) and control (1.4) groups were not different. Calpain-mediated 
spectrin breakdown products, as detected by the SBAbS2 antibody, were present 
in the corpus callosum of both the controls and the head-injured patients (Figure 
3.8). However, there was a significant increase in the optical density of the 
150kDa band detected by SBAbS2 in the head-injured patients compared to the 
controls (Figure 3.8).
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Figure 3.2 Western blot and quantitative data for neurofilament 200kDa 
dependent on phosphorylation state
Phosphorylated NF200 detected by antibody NE14 in samples o f corpus callosum 
from head-injured and control patients. H -  head-injured, C -  control. The clone 
NE14 only detects phosphorylated NF200 proteins. The top panel shows a 
Western blot o f NE14 immunoreactivity in all head-injured and control cases. H - 
head-injured patient, C - control. The graph in the bottom panel shows the 
quantitative data derived from optical density measurements o f the blot. There 
was an 80% reduction in immunoreactivity in head-injured patients, compared to 
controls. Data are mean + SEM, *** p<0.001, unpaired Student’s t test.
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Figure 3.3 Western blot and quantitative data for neurofilament 
200kDa independent of phosphorylation state.
The top panel shows the Western blot o f  antibody N52 which detects NF200 
independent o f phosphorylation state in all head-injured and control patients.
H -  head-injured C- control. The graph in the bottom panel shows the quantitative 
data derived from optical density measurements. There is a 40% reduction in the 
head-injured group compared to the controls. Data are mean + SEM, ** p<0.01, 
unpaired Student’s t test.
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Figure 3.4 Western blot and quantitative data for neurofilament 68kDa
The top panel shows a Western blot o f NF68 immunoreactivity in all head-injured 
patients and controls. H - head-injured patient, C - control. 66kDa represents the 
biotinylated molecular weight standards and the band measured for 68kDa is indicated 
by the arrow. The graph in the bottom panel shows the quantitative data derived from 
optical density measurements o f the blot as described in the methods section. There is a 
50% reduction in NF68 protein levels in the head-injured group compared to the control 
group. Data are mean + SEM; ** p< 0.01, unpaired Student’s Mest.
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Figure 3.5 Western blot and quantitative data for (3-tubulin
The top panel shows a Western blot o f (3-tubulin immunoreactivity in all head-injured 
patients and controls. H - head-injured patient, C - control. The quantitative data in the 
bottom panel shows that there was no significant difference in the levels o f (3-tubulin 
immunoreactivity between the head-injured patients and controls. Data are mean + 
SEM, unpaired Student’s t-test.
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Figure 3.6 Western blot and quantitative data for Tau 1.
Dephosphorylated tau, detected by the monoclonal antibody Tau 1 in samples o f  corpus 
callosum from head-injured and control patients. 66kDa represents the molecular weight 
standards. Since tau has various isoforms all bands were measured. The top panel shows 
a Western blot o f Tau 1 immunoreactivity in all head-injured and controls. H - head- 
injured patient, C - control. The graph in the bottom panel shows the quantitative data. 
Tau 1 immunoreactivity was slightly reduced in the head-injured patients compared to 
the controls, however this was not statistically significant. Data are mean + SEM, 
unpaired Student’s /-test.
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Figure 3.7 Western blot and quantitative data for p-calpain
p-Calpain immunoreactivity in the corpus callosum from head-injured and control 
patients. Optical density measurements were made o f  both the 80kDa and 76kDa 
bands. The Western blot in the top panel shows that both the inactive 80kDa and 
active 76kDa subunit o f p-calpain are present in both head-injured patients and 
controls. H - head-injured patient, C - control. The quantitative data reveals that 
the levels o f 80kDa p-calpain immunoreactivity were significantly lower in the 
head-injured patients compared to the controls. Data are mean + SEM. * p < 0.05 
unpaired Student’s /-test.
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Figure 3.8 Western blot for quantitative data for SBAbS2
The polyclonal antibody, SBAbS2, detected calpain-mediated spectrin breakdown 
products. H - head-injured patient, C - control. The quantitative data demonstrates that 
compared to controls, there was a 45% increase in p/m-calpain-mediated spectrin 
breakdown products in the head-injured patients. Data are mean + SEM. * p < 0.05 
unpaired Student’s t test.
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3.4.3 p-Amyloid precursor protein immunohistochemistry
p-APP-immunostained sections from formalin-fixed blocks adjacent to those used for 
Western blotting were examined by microscopy. p-APP immunoreactive axons were 
present in varying amounts in the corpus callosum of 9 out of the 10 head-injured 
patients but were absent from all control cases (Table 3.2). The different patterns of p- 
APP-stained axons due to DAI or infarction are shown in Figure 3.9. p-APP staining in 
axons damaged due to DAI shows widely distributed, multifocal swellings and or bulbs 
within white matter tracts that are not in association with haemorrhage or infarcts 
(Figure 3.9B). In contrast, the immunoreactivity seen at the edge of an infarct shows a 
different pattern consisting of a much greater concentration of abnormal profiles that 
often orientate across a straight or "Z-shaped" line (Figure 3.9A). In 5 of the head- 
injured patients the pattern of p-APP immunoreactive axonal profiles, when taken in 
conjunction with associated infarction and the interpretation of the multiple samples 
taken for diagnostic purposes, was consistent with DAI (H2,H3,H6,H7,H10 in Table 
3.2). In another 3 patients, the pattern of p-APP-stained axons was consistent with either 
arterial territory or boundary zone infarction but not DAI (HI, H8, H9 in Table 3.2). In 
patient H5 there was some p-APP staining in association with diffuse hypoxic damage 
and in the remaining patient (H4) there was no APP staining of axons, although there 
was diffuse hypoxic brain damage. Thus, in the head-injured group there was evidence 
of axonal damage due to survival mechanisms; either DAI or infarction alone, or a 
combination.
3.4.2 Calpain-mediated spectrin breakdown products 
immunohistochemistry
There was no detectable calpain-mediated spectrin breakdown products 
immunoreactivity in any of the control patients. All head-injured patients were 
immunopositive for calpain-mediated spectrin breakdown products. Staining appeared 
fragmented along axons within the white matter of head-injured patients (Figure 3.10). 
Using the same criteria to grade each section (see 3.3.3), the data shows that there is a 
correlation between the amount of p-APP immunoreactivity and calpain-mediated 
spectrin breakdown products in head-injured patients (Table 3.4 and Figure 3.11).
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Figure 3.9 Pattern of p-amlyoid precursor protein immunopositive axonal 
swellings in patients who sustained a head injury
p-APP immunostained sections o f  human corpus callosum taken from formalin- 
fixed blocks adjacent to the fresh-frozen samples used for Western blotting. A) 
Arrows indicate the edge o f  an infarct in the corpus callosum. There is a clustering 
o f immunoreactive axons that define the margin o f  an ischaemic lesion. B) 
Diffuse axonal injury in corpus callosum. In contrast to figure A the 
immunoreactive axons are not clustered but random and widely distributed 
throughout the corpus callosum. X400 Magnification.
AB
Figure 3.10 Calpain-mediated spectrin breakdown products in a control and 
head-injured patient
Adjacent sections to P-APP stained sections were immunostained for calpain-mediated 
spectrin breakdown products detected by the polyclonal antibody SBAbS2 in A) control 
and B) head-injured patient. There was no evidence o f  SBAbS2 immunoreactivity in 
any o f  the control patients. All head-injured cases immunostained with SBAbS2 
dem onstrated an increase in calpain-mediated spectrin breakdown products in white 
matter. X400 Magnification.
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Table 3.4 Scores of (3-amyloid precursor protein and SBAbS2 immunoreactivity
Case Grading of p-APP Grading of SB AbS2
HI 2 2
H2 3 3
H3 2 2
H4 0 0
H5 1 0
H6 1 2
H7 3 2
H8 3 3
H9 1 1
H10 3 3
Staining was classified as: 0 not present; 1 minimal; 2 moderate; 3 intense.
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Figure 3.11 Correlation between the amount and distribution of p-amyloid
precursor protein accumulation and calpain-mediated spectrin
breakdown products
The graph shows the relationship between the semi-quantitative scores for p-APP and 
SBABS2 immunostaining in head-injured patients. There was no p-APP or SBAbS2 
immunoreactivity observed in any of the control patients. There were three head- 
injured patients with a score of three for both p-APP and SBAbS2 immunoreactivity 
and two patients had scores of two for both p-APP and SBAbS2 immunoreactivity.
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3.5 DISCUSSION
The present study demonstrates that in the corpus callosum after blunt head injury in 
human patients, there are marked changes in proteins which are essential in maintaining 
the structural integrity of axons. The data indicate a marked loss of immunoreactivity to 
both NF200 and NF68 neurofilament proteins in head-injured patients compared to 
controls. In contrast, p-tubulin and the microtubule-associated protein, tau, were not 
affected to the same extent as the neurofilament proteins in the head-injured patients. 
Neurofilaments may therefore be more vulnerable than microtubules, in the corpus 
callosum of head-injured patients. Concomitant with these marked alterations in 
neurofilament proteins, the study also demonstrates increased levels of calpain-mediated 
spectrin breakdown products in the corpus callosum of head-injured patients, which 
suggests calpain activation. Thus, the data is consistent with the hypothesis that calpain- 
mediated cytoskeletal breakdown occurs in the corpus callosum after head-injury in 
human patients.
In the present study two different antibodies were used to detect changes in NF200 in 
the corpus callosum : N52 which detects NF200 independent of its phosphorylation 
state and NE14 which detects only the phosphorylated form of NF200. The most 
striking difference between head-injured patients and controls was detected using the 
antibody against the phosphorylated form of NF200, with a reduction of approximately 
80% compared to controls. Loss of NE14 immunoreactivity may therefore indicate 
dephosphorylation of NF200. Dephosphorylation of the normally highly phosphorylated 
sidearms of neurofilaments has been proposed to cause the compaction of 
neurofilaments in myelinated axons after TBI in experimental animals (Yaghmai and 
Povlishock 1992, Pettus et al., 1994, Povlishock 1997, Ononkwo et al., 1998). Both 
assembly/disassembly and proteolysis of neurofilaments is influenced by their 
phosphorylation state (Goldstein et al., 1987, Schlaepfer et al., 1987, Nixon and Sihag, 
1991). Pant (1988) examined phosphorylated and dephosphorylated neurofilaments 
extracted from bovine spinal cord and showed that dephosphorylated neurofilament 
proteins were more susceptible to calpain-mediated proteolysis than phosphorylated 
proteins. The mechanisms which may contribute to protein dephosphorylation after 
head injury are, as yet, unknown, although dysregulation of phosphatase and kinase 
activities are likely to arise as a consequence of alterations in axolemmal permeability
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(Pettus et al 1994). In the present study, evidence of neurofilament degradation in the 
corpus callosum of head-injured patients was also found. Using the antibody N52, 
which detects NF200 independent of its phosphorylation state, a significant reduction in 
immunoreactivity in the corpus callosum of head-injured patients compared to controls 
was detected. Taken together the data is consistent with both dephosphorylation and 
degradation of NF200 in the corpus callosum after head injury in humans. NF68 
immunoreactivity was also observed in the corpus callosum of head-injured patients 
indicating that NF68 is also degraded in myelinated fibre tracts after head injury in 
humans. NF68 was significantly reduced in the corpus callosum, detecting NF68 
independent of its phosphorylation state. Degradation of both NF200 and NF68 
neurofilament proteins have been demonstrated in the cerebral cortex underlying the site 
of injury after controlled cortical impact in the rat (Posmantur et al., 1994).
In contrast to the marked changes in neurofilament proteins in the corpus callosum of 
head-injured patients, proteins involved in the structure and function of microtubules 
were relatively unchanged compared to controls. The levels of p-tubulin 
immunoreactivity were no different between the two groups and there was only a 
modest reduction in the levels of the microtubule-associated protein tau, as detected by 
the Tau 1 antibody. Tau 1 detects only dephosphorylated tau and therefore the small 
reduction in signal in the head-injured patients could be consistent with either changes 
in the phosphorylation state of the protein or degradation. However, the results indicate 
that proteins associated with microtubules are less susceptible to the effects of head 
injury at least in the corpus callosum of the human brain. In animal models of TBI early 
and marked changes in axonal microtubules have been reported, using electron 
microscopy as an endpoint (Jafari et al., 1997; Pettus et al., 1994; Pettus et al., 1996; 
Maxwell, 1997). Thus, although there was no marked changes in p-tubulin or tau using 
Western blotting this cannot rule out that the axonal microtubular structure was 
unaffected. Microtubules play a dynamic role in the axon being involved in fast axonal 
transport, the process through which p-APP is moved along the axon (Koo et al., 1990). 
Thus, the presence of p-APP accumulations within axons of the corpus callosum in nine 
of the 10 head-injured patients examined in our study suggests that fast axonal transport 
was disrupted in p-APP-positive axons. Depolymerisation of tubulin structure, in the
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absence of the degradation of the P-isoform or changes in other microtubule-associated 
proteins may contribute to the cessation of fast axonal transport.
Based on data from experimental animal studies, breakdown of the cytoskeleton after 
head injury has been attributed to the overactivation of calpains (Kampfl et al., 1997). 
The data from this study demonstrates that both the inactive (80kDa) and active 
(76kDa) forms of p-calpain are present in the corpus callosum of head-injured patients. 
There was a reduction in the level of the 80kDa form in the head-injured patients in 
comparison to the controls, while there was no significant difference between the two 
groups in the 76kDa form. There was no difference between the groups in the ratio of 
the active: inactive forms of the enzyme. In addition, however, there was an increase in 
the levels of calpain-mediated spectrin breakdown products in the corpus callosum of 
the head-injured patients. Thus, it is possible that calpain may be involved in spectrin 
degradation in axons after head injury. The polyclonal antibody SBAbS2 used in this 
study is analogous to Ab38, and specifically detects calpain-mediated spectrin 
breakdown products (Robert-Lewis et al., 1994). Calpain-mediated spectrin breakdown 
products immunostained sections illustrated axonal fragmentation in the white matter 
tracts of the corpus callosum. Increased immunostaining of subcortical white matter 
with the Ab38 antibody has been reported within 90 minutes of lateral fluid percussion 
injury in the rat (Saatman et al., 1996a) although this was not observed until 24 hours 
after controlled cortical impact in the rat (Newcomb et al, 1997). The majority of the 
head-injured patients in this study had survived for longer than 24 hours after their 
primary injury and the limited size of the group examined did not permit analyses to 
determine the time course of relative changes in calpain levels, activation and 
neurofilament protein loss. However, it is interesting to note that spectrin associates 
specifically with a 30kDa fragment from the amino terminus of neurofilament (Nixon 
and Sihag 1991). Therefore, it might be speculated that if spectrin is rapidly degraded 
by calpains, and neurofilaments are freed from the spectrin cytoskeleton, this may have 
an impact on the susceptibility of neurofilament proteins to pathological mechanisms 
after injury.
Calpain-mediated breakdown of the cytoskeleton has also been implicated in the 
pathogenesis of ischaemic brain damage (Roberts-Lewis et al., 1994; Hong et al., 1994;
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Bartus et al., 1995). In any given head-injured patient changes in axons may be present 
for various reasons only some of which can be attributed to trauma per se (Gennarelli et 
al., 1998, Graham and Gennarelli 1997) In patients who die after head-injury a 
principal cause of axonal damage is ischaemia in association with haemorrhage and the 
complications of internal herniation due to raised intracranial pressure (Graham etal., 
1989; Graham et al., 1987). Therefore, in the assessment of axonal damage after trauma 
it is necessary to undertake a comprehensive neurohistological study of multiple 
bilateral brain regions in order to determine not only the presence of axonal damage but 
also its distribution, and to determine the relationship between it and the various other 
pathologies of traumatic brain injury. This task has been greatly facilitated with the 
advent of immunohistochemistry and in particular for amyloid precursor protein 
(Gentleman et al., 1993, Sherrif et al., 1994, McKenzie et al., 1996; Blumbergs et al., 
1989) which is both sensitive in the detection of axonal changes and the identification of 
abnormalities within a few hours of injury. By this means it is now possible to identify 
the presence of DAI and to determine its severity (Adams et al., 1989; Gentleman et al., 
1995). The use of p-APP immunohistochemistry in this study determined a number of 
important aspects of axonal damage. First, the head injury patients had lived long 
enough for changes to have developed (minimal survival of 4 hours). Secondly, that 
the variable post mortem interval (range from 34 to 72 hours) did not alter the 
sensitivity of the method, thirdly it identified P-APP-positive immunoreactive axons in 
the corpus callosum in nine of the 10 head-injured patients and fourthly the distribution 
of the axonal changes to be determined and correlated with the presence of hypoxic 
brain damage including infarction. In this way it was possible to attribute the axonal 
changes in the corpus callosum to either DAI, infarction or a combination of both.
It has been previously demonstrated that abnormalities in cytoskeletal proteins and p- 
APP accumulation occur in myelinated fibre tracts after a focal ischaemic insult in the 
rat (Dewar & Dawson, 1995; Yam et al., 1997; Yam et al., 1998) while others have 
reported accumulation of P-APP in white matter at the margin of an ischaemic lesion in 
human brain (Oghami et al., 1992; Suenaga et al., 1994, Jendroska et al., 1997). Due to 
the limited number of patients in subgroups of the head-injured patients we did not 
make a formal analysis comparing those with ischaemia or diffuse axonal damage 
alone. However, the percentage reduction compared to controls in neurofilament signal
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was similar in patients who had diffuse or ischaemic damage (approximately 80% in 
each subgroup) as was the percentage increase in calpain-mediated spectrin breakdown 
products (40% in each subgroup). Thus, in head-injured patients cytoskeletal disruption 
and accumulation of p-APP in axons of the corpus callosum may be a consequence of 
either primary traumatic or secondary ischaemic injuries. However, the mechanism by 
which these types of pathologies are manifest may involve overactivation of calpains. 
Both p-APP and calpain-mediated spectrin breakdown products were graded semi- 
quantitatively according to their immunoreactivity. In the head-injured patients there 
was a close correlation between the two scores, reinforcing the suggestion that calpain 
activity is involved in axonal degeneration. Thus calpain inhibition may prove to be a 
potent therapeutic strategy for attenuation of both neuronal and axonal damage, due to 
either trauma or after a stroke.
From this study and other research it can be speculated that calpain-mediated 
proteolysis is involved in cytoskeletal breakdown following acute brain injury. 
However, it is possible that axonal damage is not solely due to calpains and that other 
mechanisms could be involved in axonal degeneration. Another important mechanism 
thought to play a major role in acute brain injury is oxidative stress. Calpains may have 
an integral link to increasing free radicals and free radicals can increase the autolysis of 
calpains indirectly by increasing intracellular Ca (Figure 3.12).
Therefore in the next part of the thesis experimental studies were undertaken to examine 
the role of oxidative damage and its association with calpain activation in axonal 
damage
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Figure 3.12 Cascade of biochemical events after human head injury
ACUTE BRAIN INJURY
DAMAGED AXOLEMMA ENERGY FAILURE
FREE RADICALS
CALPAINS
The diagram illustrates that following head injury alterations in axolemmal permeability 
leads to Ca activated proteases, calpains. However, it also proposes that primary 
mechanisms, calpain activation and free radicals could have a complex interaction.
CHAPTER IV
WHITE MATTER DAMAGE FOLLOWING SYSTEMIC INJECTION OF 
THE MITOCHONDRIAL INHIBITOR 3-NITROPROPIONIC ACID
4.1 INTRODUCTION
Oxidative stress has been proposed to play a major role in the pathogenesis of neuronal 
cell death following acute brain injury (Watson et al., 1984; Doopenberg et al., 1998; 
see reviews Flamm et al., 1978; Chan 1994; Murphy et al., 1999; Love 1999). One of 
the major cellular organelles responsible for excessive production of superoxide ions is 
the mitochondria (Dugan et al., 1995; Piantadosi and Zhang 1996). During ischaemia, 
oxidative phosphorylation becomes uncoupled leading to decreased ATP synthesis and 
increased superoxide production (Cino & Del Maestro 1989; Shigenaga et al., 1994). 
Rapid catalysis of superoxide anion can be reduced to hydrogen peroxide and then 
catalysed to the potent hydroxyl radical in the presence of Fe+ ions. Endogenous 
antioxidants become saturated and cannot remove excess radicals that then go onto 
enhance the oxidative stress cascade. Although, there is an overwhelming body of 
evidence proposing a role for oxidative stress in perikaryal damage there is little 
evidence in the literature suggesting that white matter is vulnerable to oxidative stress.
3-Nitropropionic acid (3-NPA) is a plant myotoxin, which is an irreversible inhibitor of 
succinate dehydrogenase in the Krebs cycle and complex II of the electron transport 
chain (Alston et al., 1977; Coles et al., 1979; Alexi et al., 1998) (Figure 4.1). This toxin 
impairs energy metabolism and increases lactate (Brouillet et al., 1993; Tsai et al., 
1997) and has been shown to produce selective striatal lesions in both experimental 
animal models and in man (Ludolph et al., 1991). Hippocampal slices treated with 3- 
NP A demonstrated both a rapid necrotic cell death that was NMDA receptor-dependent 
and a delayed non NMDA-receptor dependent apoptotic cell death (Pang and Geddes 
1997). Systemic injection of 3-NPA in vivo induces generation of free radicals (Schulz 
etal., 1996).
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Figure 4.1 Electron transport chain located on the inner mitochondrial membrane
Modified from Murphy et al., 1999.
The diagram illustrates the electron transport chain where oxidative phosphorylation 
occurs. 3-Nitropropionic acid inhibits succinate dehydrogenase at complex II, thus 
elevating the production of superoxide anions which in turn causes oxidative stress.
To determine if oxidative stress played a role in axonal cytoskeletal breakdown and 
alterations in calpain activity, 3-nitropropionic acid was systemically injected into rats.
Animals received an intraperitoneal injection of 10,15, 20 or 30mg/kg 3-NPA or sterile 
water (n = 4/5 per group) and were transcardially perfused with 4% paraformaldehyde 
24 hours later. Rats were decapitated and heads post-fixed for 24 hours. Brains were 
removed and post-fixed for a further 48 hours and then brains were processed for 
paraffin embedding (see 2.4.2). 5pm sections were cut for histology and stained with 
cresyl fast violet and luxol fast blue. Cresyl fast violet staining was used to determine
4.2 AIM
4.3 MATERIALS AND METHODS
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morphological changes detected in the neuronal perikarya and similar changes have 
been described in other studies after systemic injection of 3-NPA (Beal et al., 1995). 
Luxol fast blue staining was used to determine if there were histological changes in 
myelinated axons. To determine if there were changes in the axonal cytoskeleton rat 
brain sections were immunostained with the transport proteins P-APP and SNAP-25. 
Adjacent sections were stained with the polyclonal antibody SBAbS2 to detect if there 
were alterations in calpain activity. Rat brain sections were also stained with Mn-SOD 
to confirm the role of oxidative stress in this model.
4.3.1 Assessment of axonal damage
Immunostained sections from each group, taken at the level of the anterior commissure, 
were analysed microscopically and each section scored according to the amount and 
distribution of immunoreactive axons within the striatum. A score of 0 was given to 
sections with no immunostaining; 1 for minimal immunoreactivity; 2 for moderate 
staining and 3 for dense immunostaining. Each section was graded blind to the identity 
of the treatment of the animal.
4.3.2 Assessment of glial cell staining
A 1cm square graticule was used to count the oligodendrocyte-like cells 
immunopositive for calpain-mediated spectrin breakdown products in three different 
loci along the subcortical white matter at the level of anterior commissure (Figure 4.2). 
Oligodendrocytes were identified by their characteristic morphology of a small soma 
and thin rim of cytoplasm. Cells were counted and expressed as cells per mm2.
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Figure 4.2 Rat brain section at the level of the anterior commissure
Neuronal perikaryal damage was observed bilaterally within the dorsolateral region of 
the striatum at all concentrations of 3-NPA systemic injection. There was no neuronal 
perikaryal damage observed in the cortex. Dotted lines represent the areas of neuronal 
damage. In the 3-NPA treated groups oligodendrocyte-like cells were immunopositive 
for calpain-mediated spectrin breakdown products, detected by SBAbS2 only in the 
subcortical white matter. The density of these cells was determined at the points 
indicated by the arrows.
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4.4 RESULTS
4.4.1 Histology
Morphological changes in neuronal perikarya were observed at all the concentrations of 
3-NPA administered. However, the most severe histological changes were observed 
following systemic injection of 30mg/kg 3-NPA, the highest concentration. Therefore 
only photographic data from vehicle and 30mg/kg treated groups is presented in this 
chapter. For 10, 15 and 20mg/kg 3-NPA immunostained sections see appendix 3. 
Morphologically normal spherical-shaped neurons and axons within the striatum were 
observed in the vehicle treated animals (Figure 4.3A). In contrast, systemic injection of 
3-NPA at all concentrations produced a bilateral lesion in the striatum while no 
neuronal damage was observed in the cortex. Throughout the lesion there were 
shrunken neurons and disrupted myelinated fibre tracts (Figure 4.3B). Cresyl fast violet 
and luxol fast blue stained sections demonstrated a typical pattern of 3-NPA induced 
neurotoxicity (Beal et al., 1993; Brouillet et al., 1993; Wuulner et al., 1994; Borlongan 
et al., 1995).
4.4.2 Axonal pathology
There was no evidence of p-APP accumulation in axons in the vehicle treated animals 
(Figure 4.4A). Accumulation of protein was detected after 3-NPA injection only within 
the myelinated fibre tracts of the striatum. Intense widespread p-APP immunoreactive 
axonal swellings were observed in the 30mg/kg treated group (Figures 4.4B). There was 
no evidence of SNAP-25 immunoreactivity in the vehicle treated group (Figure 4.5A). 
A striking increase in the density of SNAP-25 immunoreactive axonal swellings and 
bulbs within the myelinated fibre tracts was observed in animals injected with 30mg/kg 
3-NPA (Figure 4.5B). All P-APP and SNAP-25 immunoreactive axons were restricted 
to the myelinated fibre tracts in the striatum. Axonal pathology was anatomically 
coincidental with the neuronal lesion. Using the scoring system described in 4.3.1 there 
was a concentration dependent increase in axonal pathology, reflected in p-APP (Figure 
4. 6) and SNAP-25 (Figure 4.7) accumulation in the 3-NPA treated animals. The 
amount of P-APP (Table 4.1) and SNAP-25 (Table 4.2) immunoreactivity varied 
between animals within each group.
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Figure 4.3 Morphological changes in the striatum following systemic injection of 
3-nitropropionic acid
Cresyl fast violet and luxol fast blue histology in A) vehicle and B) 30mg/kg 3-NPA 
treated rat. In the vehicle treated rats neuronal perikarya exhibited the characteristic 
morphology o f  normal neurons (arrows) while myelinated axons had a smooth regular 
appearance (arrow heads). In 30mg/kg 3-NPA treated animals there was shrinkage o f 
neuronal perikarya in the striatum (arrows). Myelinated axons stained with luxol fast 
blue had a disrupted appearance compared to the vehicle within the striatal white matter 
bundles (arrow heads). X400 Magnification.
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AFigure 4.4 p-amy!oid precursor protein immunohistochemical staining in the 
striatum following systemic injection of 3-nitropropionic acid
P-APP, immunostaining in A) vehicle and B) 30mg/kg treated animals. No p-APP 
immunostaining was evident in axons in the vehicle treated group, This was a typical o f 
pattern o f immunoreactivity that was given a score o f  0. In the 30mg/kg treated animals 
p-APP immunoreactivity demonstrated axonal bulbs and swellings in the striatal white 
matter tracts. This was a typical pattern that represents a score o f  3. The arrows indicate 
p-APP axonal bulbs. X 400 Magnification.
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AFigure 4.5 SNAP-25 immunohistochemical staining in the striatum following 
systemic injection of 3-nitropropionic acid
SNAP-25 immunostaining in A) vehicle and B) 30mg/kg 3-NPA treated rat. There was 
no SNAP-25 immunostaining in the vehicle treated group. This was a typical pattern o f 
immunoreactivity that was given a score o f three SNAP-25 immunoreactivity 
accumulated in myelinated fibre tracts o f  the striatum in 30mg/kg treated animals. This 
was a typical pattern o f  immunoreactivity that was given a score o f  3. The arrow 
indicates SNAP-25 axonal bulbs. X400 Magnification.
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Table 4.1 Scores of P-amyloid precursor protein immunoreactivity following 
3-nitropropionic acid injection
Animal No Vehicle 1 Omg/kg 15 mg/kg 2 Omg/kg 3 Omg/kg
1 0 0 1 2 3
2 0 1 0 1 3
3 0 0 1 1 3
4 0 1 1 2 3
5 0 1 1 3
Staining was classified: 0, not present; 1, minimal; 2, moderate, 3, intense J3-APP accumulation;
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Figure 4.6 p-amyloid precursor protein accumulation following increased 
concentrations of 3-nitropropionic acid
p-APP immunoreactive sections were graded and given a score o f  either 0 = none;
1 = minimal; 2 = moderate and 3 = intense immunostaining. There was no p-APP 
immunoreactivity in axons in vehicle treated animals and only one animal out o f four 
and three out o f  five in 10 and 15mg/kg 3-NPA treated animal, respectively, 
demonstrated any evidence o f P-APP immunoreactivity. Animals treated with 20mg/kg 
3-NPA all had evidence o f p-APP immunoreactive swellings although this varied in the 
intensity o f immunostaining. All five animals in 30mg/kg 3-NPA treated groups 
demonstrated bilateral p-APP accumulation throughout the white matter bundles in the 
striatum and all scored three. Data are mean + SEM. Kruskal-Wallis test p<0.0007
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Table 4.2 Scores of SNAP-25 immunoreactivity following 3-nitropropionic acid
injection
Animal No Vehicle 1 Omg/kg 15 mg/kg 2 Omg/kg 3 Omg/kg
1 0 0 0 1 3
2 0 1 1 1 2
3 0 0 1 2 2
4 0 0 0 1 2
5 0 0 0 3
0, not present; 1, minimal; 2, moderate, 3, intense SNAP-25 accumulation;
& 3
0 10 15 20 30
(n = 5) (n = 4) (n = 5) (n = 5) (n = 5)
Concentration o f 3-NPA (mg/kg)
Figure 4.7 SNAP-25 accumulation following increased concentrations of 
3-nitropropionic acid
SNAP 25 immunoreactive sections were graded and given a score o f either 0 = none;
1 = some; 2 = moderate and 3 = intense immunostaining in axons. The data shows that 
there is no immunostaining in the vehicle treated group and that only one out o f four 
and two out five animals in the 10 and 15mg/kg 3-NPA treated group, respectively had 
evidence o f  SNAP-25 accumulation. SNAP-25 immunoreactive axons were present in 
four out the five animals in the 20mg/kg treated group, although the amount o f  SNAP- 
25 ranged not present, to some to moderate between animals. The amount o f  SNAP-25 
immunostaining varied between animals but all five animals in the 30mg/kg treated 
group had evidence o f SNAP-25 immunoreactivity within the striatum. Data are mean + 
SEM. Kruskal-Wallis test p<0.0023
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4.4.3 Calpain-mediated spectrin breakdown products 
immunohistochemistry
The polyclonal antibody, SBAbS2 specifically detects calpain-mediated spectrin 
breakdown products. In the vehicle treated animals only a few immunopositive 
oligodendrocyte-like cells were present within the subcortical white matter (Figure 4.8A 
and Figure 4.9). In the 3-NPA treated animals there was a concentration dependent 
increase in the density of SBAbS2 immunopositive cells present in the subcortical white 
matter at the level of the anterior commissure (Figure 4.8B and Figure 4.9). The number 
of oligodendrocyte-like cells which were positive for SBAbS2 was increased three-fold 
in the 30mg/kg treated animals compared to the vehicle treated animals. There was 
evidence of SBAbS2 immunopositive oligodendrocyte-like cells in the myelinated fibre 
tracts within the striatum, however, these cells were only present in the 3Omg/kg treated 
animals and were therefore not counted. There was evidence of these cells in the 
myelinated fibre tracts of the striatum only in the 30mg/kg treated group and therefore 
these cells were not counted.
4.4.4 Manganese superoxide dismutase immunohistochemistry
Manganese superoxide dismutase (SOD-2) is located within the mitochondria. The 
mitochondria is a subcellular source of ROS (Dugan 1995) and Mn-SOD detoxifies 
ROS produced under normal physiological conditions. In the vehicle treated group there 
was a basal level of Mn-SOD immunoreactivity present within the subcortical white 
matter and striatum (Figure 4.10A). In the 3-NPA treated animals there was a 
concentration dependent increase in Mn-SOD immunoreactivity in the striatum (Figure 
4.1 OB). There was no increase in Mn-SOD observed in the subcortical white matter in 
any of the 3-NPA treated groups.
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Figure 4.8 Immunohistochemical staining of calpain-mediated spectrin
breakdown products in the subcortical white m atter following 
systemic injection of 3-nitropropionic acid
The polyclonal antibody, SBAbS2 detected calpain-mediated spectrin breakdown 
products in oligodendrocyte-like cells in A) vehicle and B) 30mg/kg 3-NPA treated 
rat. Negligible staining o f  oligodendrocyte-like cells was evident in the subcortical 
white matter in vehicle treated group. However, there was intense SBAbS2 
immunostaining o f  oligodendrocyte-like cells in the 30mg/kg 3-NPA treated group. The 
arrow indicates a typical positively stained oligodendrocyte with the characteristic small 
soma and thin rim o f  cytoplasm. X400 Magnification.
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Figure 4.9 Quantitative data representing SBAbS2 immunopositive 
oligodendrocyte-like cells following systemic injection of 
3-nitropropionic acid
Oligodendrocyte cells were counted in the subcortical white matter at the level o f the 
anterior commissure at three specified regions (Figure 4.2). Cells were counted 
microscopically using a 1cm square graticule at x400 magnification and expressed as 
the number o f cells per mm2. The data show that there was a concentration dependent 
increase in the number o f SBAbS2 immunopositive oligodendrocyte-like cells. Data are 
mean + SEM. one way ANOVA post-tested with Students t test and corrected with 
Bonferroni.
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Figure 4.10 Manganese superoxide dismutase immunostaining following 
systemic injection of 3-nitropropionic acid
Mn-SOD immunoreactivity in the striatum o f A) vehicle and B) 30mg/kg 3-NPA 
treated rat. There was some evidence o f Mn-SOD immunostaining in the vehicle treated 
animals within the striatum. In contrast to the vehicle treated animals, Mn-SOD 
immunoreactvity was increased in the 30mg/kg treated group throughout the striatum. 
Mn-SOD appeared to be present in neuronal cells but not in axons. The arrow indicates 
Mn-SOD positive necrotic neurons. X400 Magnification.
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4.5 DISCUSSION
Systemic injection of 3-nitropropionic acid induced marked pathological changes in 
myelinated axons in the striatum. There was a concentration dependent increase in the 
amount and distribution of axonal pathology reflected by the accumulation of the 
axonally transported proteins p-APP and SNAP-25. The gallyas silver staining 
technique, another method used to identify axonal damage, detected changes in axonal 
pathology up to two days post-injection of 3-NPA (Miller and Zaborszky 1997). In the 
present study, semi-quantitative analysis revealed no protein accumulation in either the 
subcortical white matter or the striatal fibre tracts in the vehicle treated group. Minimal 
immunoreactivity of both p-APP and SNAP-25 in the 10 or 15mg/kg 3-NPA treated 
animals was apparent and axonal damage detected by p-APP and SNAP-25 was slightly 
increased following 20mg/kg 3-NPA. However, after 30mg/kg 3-NPA two out of the 
five animals had moderate SNAP-25 staining and an intensely stained profile of axonal 
pathology was present in the other remaining three animals. In contrast, all five animals 
treated with 30-mg/kg 3-NPA demonstrated intense widespread accumulation of p-APP 
in the fibre tract bundles of the striatum. Scoring the amount and distribution of p-APP 
and SNAP-25 accumulation in axons revealed that the extent of axonal pathology was 
related to the concentration of 3-NPA administered. Using a similar paradigm, Brouillet 
et al., 1998 demonstrated a concentration dependent reduction in succinate 
dehydrogenase staining in the striatum following systemic injection of 3-NPA. 
However, in the present study the type of axonal pathology present in the striatum was 
not evident in the subcortical white matter. Structural alterations in the somatodendritic 
cytoskeleton are induced by intracerebral injection of 3-NPA. A loss of MAP-2 
immunoreactivity was observed after 3-NPA treatment indicating a disruption of the 
cytoskeleton that is essential for stability and maintenance of dendritic and perikaryal 
structure and function. Thus, components of both the axonal and perikaryal cytoskeleton 
could be vulnerable to free radical mediated damage induced by 3-NPA.
Other mechanisms have also been proposed as pathogenic mediators involved in 3-NPA 
induced damage. Pang (1997) detected two different types of cell death in hippocampal 
slices after 3-NPA treatment: a rapid necrotic cell death that was NMDA receptor 
dependent and a delayed non NMDA-receptor dependent apoptotic cell death (Pang and
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Geddes 1997). This suggests that mitochondrial dysfunction could induce a number of 
different pathogenic factors. Impaired energy metabolism reduces the amount of ATP 
available, leading to membrane depolarisation and this will relieve the Mg+ block on the 
NMDA receptor (Riepe et al., 1995; Greene et al., 1998). NMDA receptor activation by 
glutamate leads to Ca influx. Calcium overload could in turn lead to activation of 
calpains suggesting a mode of action in grey matter. In the previous chapter of the thesis 
breakdown of the axonal cytoskeleton was associated with an increased activation of 
calpains after human head injury. However, after 3-NPA treatment in the rat, calpain- 
mediated spectrin breakdown products were not present within damaged axons. This 
contrasts with the findings in patients who had sustained a blunt head injury where there 
was evidence of calpain-mediated damage within axons. This suggests that 3-NPA 
administration in rats did not cause calpain activation in axons. Thus the axonal 
pathology induced by 3-NPA may reflect other actions of free radicals on the axonal 
cytoskeleton. By contrast, calpain-mediated spectrin breakdown products were 
increased in oligodendrocyte-like cells after 3-NPA treatment. Geddes et al., 1994, 
reported that intracerebral injection of 3-NPA induced calpain activation within neurons 
and this supports the suggestion that there is an interaction between oxidative stress and 
calpain activation, at least in neurons and oligodendrocytes. The oxidative stress 
cascade can increase the amount of intracellular Ca2+ (Dykens 1994; Desphande et al., 
1997; Silver and Ercinska 1990) which could lead to calpain activation. Immunopositive 
oligodendroctyes was restricted to the subcortical white matter and was not present in 
the myelinated fibre tracts of the striatum where axonal damage was evident. However, 
increased calpain-mediated spectrin breakdown products were detected in 
oligodendrocytes in the striatum in response to the highest concentration of 3-NPA. 
Although, there were reduced levels of succinate dehydrogenase activity in the corpus 
callosum after 3-NPA treatment in the rats (Brouillet et al., 1998) this study did not 
distinguish between axons and oligodendrocytes and thus may explain why there was no 
protein accumulation in axons in the subcortical white mater. Therefore, this data 
suggests that neurons, axons and glia cells could have different sensitivities to 
pathogenic mechanisms. Therefore, although mitochondrial inhibition constitutes the 
primary insult after 3-NPA injection (Takamatsu et al., 1998) secondary mechanisms 
such as calpains, excitotoxity and oxidative stress may also be responsible for cellular 
damage.
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There was a concentration dependent increase in the amount and distribution of Mn- 
SOD cellular staining in the striatum following 3-NPA treatment. A basal level of Mn- 
SOD immunopositive cells was present in the vehicle treated group. In the 30mg/kg 
treated group Mn-SOD immunoreactive cells appeared to be coincident with necrotic 
neurons within the striatum. Immunostaining did not appear to be increased in the 
subcortical white matter in any of the 3-NPA treated animals. This result concords with 
a previous study which demonstrated increased levels of Mn-SOD and the cytosolic 
Cu/Zn-SOD enzymes in the striatum following 3-NPA injection (Binienda et al.,1998). 
Both studies indicate that the levels of endogenous antioxidants are increased after 3- 
NPA treatment. Although, 3-NPA induced pathological changes, antioxidant enzymes 
may become overwhelmed by the intensity of free radical production and this may lead 
to tissue damage. There was a difference in the type of pathology observed in the 
striatum and the subcortical white matter yet they both had similar reductions in 
succinate dehydrogenase activity after 3-NPA administration (Brouillet et al., 1998). 
Therefore following 3-NPA injection, axonal damage in the striatum could be due to 
oxidative stress whereas the increased number of oligodendroctye-like cells in the 
subcortical white matter could be due to calpain activation. Furthermore, the presence of 
P-APP accumulation in axons within the striatum but not in axons within the subcortical 
white matter suggests that there may also be a differential tissue response to 3-NPA as 
well as multiple mechanisms involved.
Initiation of the self-propagating process, lipid peroxidation, may also enhance 3-NPA 
neurotoxicity. Systemic injection of 30mg/kg 3-NPA significantly increased the amount 
of free fatty acids, a marker of lipid peroxidation (Binienda et al., 1997). Reduction of 
the nitro moiety on 3-NPA produces superoxide anions (Fu et al., 1995) and these 
anions can undergo reactive changes to form either the hydroxyl radical or peroxynitrite 
anions, which can in turn induce lipid peroxidation. Therefore, a complex interacting 
cascade of pathogenic mechanisms leading to white matter damage could be 
hypothesised (Figure 4.11). In the next study the ability of the lipid peroxidation by 
product, 4-hydroxynonenal to induce axonal or oligodendrocyte damage was 
determined.
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Figure 4.11 Cascade of biochemical events after acute brain injury
ACUTE BRAIN INJURY
DAMAGED AXOLEMMA ENERGY FAILURE
FREE RADICALS
CALPAINS LIPID PEROXIDATION
The digram illustrates a more complex interaction between pathogenic mediators than 
demonstrated in Figure 3.12. Oxidative cascade could contribute to cellular damage 
through initiation of the self-propagating process, lipid peroxidation.
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CHAPTER V
THE LIPID PEROXIDATION BY-PRODUCT 4-HYDROXYNONENAL IS
TOXIC IN  VIVO AND IN  VITRO
5.1 INTRODUCTION
Lipid peroxidation is an autocatalytic event that continues by abstracting hydrogen 
atoms from polyunsaturated fatty acids (Radi et al., 1991; Darely-Usmar 1992; Rubbu et 
al., 1994; Braughler and Hall 1989a; Braughler and Hall 1989b). As well as a long 
lasting effect on membrane integrity, lipid peroxidation releases an aldehyde cytotoxic 
by-product, 4-hydroxynonenal (4-HNE) (Esterbauer et al., 1991) which may itself 
contribute to cellular damage. 4-HNE has been shown in vitro to covalently bind to 
cytoskeletal proteins (Montine et al., 1996a; Mattson et al., 1997), ionic transporters 
(Siems et al., 1996) and neurotransmitter transporters (Springer et al., 1997; Keller et 
al., 1997; Blanc et al., 1998). These actions could lead to increased production of 
reactive oxygen and nitrogen species (Kinter and Roberts 1996; Karlbuber et al., 1997; 
Keller et al., 1997; Martinez et al., 1997) increased levels of intracellular calcium or 
induce excitotoxicity (Springer et al., 1997; Keller et al., 1997; Blanc et al., 1998). 
Increased 4-HNE immunoreactivity was present in white matter tracts surrounding the 
site of impact in a rat model of spinal cord injury (Springer et al 1997) and this lipid 
peroxidation product has been shown to be directly toxic to neuronal perikarya both in 
vitro and in vivo. (Bruce-Keller et al., 1998). However, it is not known if 4-HNE is toxic 
to white matter.
5.2 AIM
The aims of this study were threefold. Firstly, to determine if exogenous 4-HNE 
damages axons in vivo. Secondly, to determine if exogenous 4-HNE is toxic to 
oligodendrocytes in culture in vitro and thirdly to determine if endogenous 4-HNE is 
present in myelinated axons after permanent focal cerebral ischaemia.
5.3 MATERIALS AND METHODS
5.3.1 Intracerebral injection of 4-hydroxynonenal, ethanol and 
artificial cerebrospinal fluid in rats
Sprague Dawley rats were anaesthetised and placed in a stereotaxic frame. An incision 
was made in the scalp and the skull exposed. A craniotomy was made using a dental 
drill and using a Hamilton syringe 0.5pl of 64mM 4-HNE (n=6), vehicle (ethanol n=5)
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or artificial cerebral spinal fluid (aCSF) (n=3) was injected into the subcortical white 
matter (Figure 5.1) at stereotaxic co-ordinates (A/P = -0.26mm from Bregma, L/M = 
2mm and D/V = 3mm). 4-HNE, ethanol or aCSF were injected at a rate of 0.1 pi per 
minute and the needle left for 10 minutes before removal to allow diffusion of the 
injectate from the needle tip. Animals were allowed to survive for 24 hours and then 
transcardially perfused with 4% paraformaldehyde. Brains were removed and 
processed for paraffin embedding and 5 pm sections cut for histology and 
immunohistochemistry.
5.3.1.2 Volumetric analysis of lesion
Serial sections were cut throughout the lesion. Every tenth section was stained with H & 
E and the area of pallor within the sections was determined using an imager analyser 
(Imaging Research, Canada). All sections were measured and normalised to a cyrostat 
non-fixed rat brain to correct for shrinkage that may have occurred during the fixation 
and paraffin embedding process. The area of damage in mm2 was plotted against the 
distance between sections and the area under the curve was used to calculate the volume 
of damage in mm . Statistical analysis was performed using a one way ANOVA and 
post tested using Student’s t test and corrected with Bonferroni for multiple 
comparisons.
5.3.1.3 Immunohistochemistry
Immunohistochemistry was performed (see 2.7.1) using DAB as the chromogen. 
Adjacent sections were processed for p-APP to assess axonal injury, a polyclonal 
antibody raised against 4-HNE which detects 4-HNE-Michael adducts and the 
polyclonal antibody SBAbS2 to determine if there was any evidence of calpain- 
mediated spectrin breakdown products. For information of primary antibodies see Table 
2 . 1.
91
£ v?;
Figure 5.1 Digitised image of haematoxylin and eosin stained sections showing 
histological damage
Digitised images o f representative sections at the coronal plane showing areas o f 
histological damage in rats injected with: A) 4-HNE; B) ethanol and C) aCSF. The 
arrows in each section indicate the injection site and the dotted lines delineate the areas 
o f pallor, defining the extent o f histological damage measured using the image analyser. 
Serial sections throughout the extent o f the lesion were measured and the volume o f the 
histological lesion calculated.
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5.3.1.4 Quantitative analysis of neuronal perikarya damage and 
axonal injury
Using a previously described method (Yam et al., 1999) the extent of neuronal 
perikaryal damage in grey matter and axonal injury in subcortical white matter was 
determined in all three treated groups. Neuronal damage was assessed in haematoxylin 
and eosin stained sections and axonal injury was assessed in adjacent p-APP stained 
sections. Neuronal damage was defined by the presence of pyknotic eosinophilic 
perikarya and axonal damage was defined by the presence of p-APP positive axonal 
bulbs or swellings in white matter. The areas of grey and white matter damage were 
quantified by placing a 1mm2 grid on a transparency over the diagrams and counting the 
number of grid points that fell within the lesion area (Figure 5.2).
5.3.2 Effect of 4-hydroxynonenal on oligodendrocyte cultures
Oligodendrocyte cultures were prepared from Sprague Dawley neonates (0-3 days old) 
and enzymatically dissociated and mixed glia cells plated for 10-12 days (see 2.7.1). 
Thereafter cultured flasks were shaken overnight in an orbital shaker and filtered to 
obtain pure oligodendrocyte cultures (see 2.7.2). Mature oligodendrocytes were 
identified in vitro using galactocerebroside immunofluorescent labelling (Figure 2.5). 
After seven days in culture, cells were exposed to 1, 10 or 50pM 4-HNE and incubated 
for either 1, 2 or 4 hours (see 2.7.6). Concentrations of 4-HNE are within the range 
known to induce damage in cells exposed to FeSC>4 and other insults that induce 
membrane lipid peroxidation. (Esterbauer et al., 1991; Mark et al., 1997). 
Oligodendrocyte cell death was determined by trypan blue exclusion (see 2.7.5) and 
morphological changes detected by immunohistochemistry (see 2.1.7) using a 
monoclonal antibody to the cytoskeletal protein spectrin (Table 2.1).
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Figure 5.2 Mapping of grey and white matter damage onto digitised images of 
haematoxylin and eosin stained sections from 4-hydroxynonenal, 
ethanol and artificial cerebrospinal treated animals
Digitised images o f  representative sections at the coronal plane o f  histological damage 
in rats injected with A) 4-HNE, B) ethanol and C) aCSF. The area o f neuronal damage 
is outlined in red and axonal injury is outlined black. Perikaryal damage was determined 
by their characteristic necrotic appearance while axonal injury was determined by the 
presence o f  p-APP bulbs and swellings.
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5.3.3 Permanent focal cerebral ischaemia
Male Sprague Dawley rats (Harlan Olac, UK) weighing between 270-320g were housed 
together before surgery and individually housed afterwards in a cage with soft bedding, 
food and water throughout the 24 hour recovery period. Animals were anaesthetised 
with 5% halothane and 70% nitrous oxide/30% oxygen in a perspex box (n = 6). Rats 
were then intubated with a 16G catheter and mechanically ventilated with 1.5% 
halothane and 70% nitrous/30% oxygen. Focal cerebral ischaemia was induced by the 
intraluminal thread method (Longa et al., 1989). A neck medial incision was made and 
the left common carotid artery exposed. The pterygopalatine branch of the internal 
carotid was ligated with a 6.0 silk suture. The external carotid was electrocoagulated 
distally and an aneurysm clip placed on the common and internal artery while an 
artertiotomy was made in the external carotid and a 6.0 nylon monofilament suture 
advanced to the clip on the internal carotid. The clip was removed and the 
monofilament suture was advanced up for approximately 22mm or until some resistance 
was felt to block the origin of the middle cerebral artery. After 2 hours the animals 
recovered with the thread still in place. The muscle and skin of the neck incision were 
sutured and 0.5mls of atropine and 2mls of sterile saline given subcutaneously. Animals 
were allowed to recover for a period of 22 hours and during this period monitored for 
any gross behavioural changes. Animals were then re-anaesthetised, with 5% halothane 
70% nitrous/30% oxygen in a perspex box and then perfused transcardially with 0.9% 
saline and 4% paraformaldehyde. Rats were decapitated, heads post-fixed for 24 hours 
in 4% paraformaldehyde, brains removed and post-fixed for a further 48 hours before 
being processed through a series of dehydrating and clearing agents and then paraffin 
embedded (see 2.4.2). 5pm microtome sections were collected onto poly-L-lysine slides 
for histology and immunohistochemistry.
All surgical procedures and tissue processing for these experiments were performed by 
Dr.V.Valeriani. Immunohistochemistry experiments was performed by E. McCracken.
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5.4 RESULTS
5.4.1 Intracerebral injection of 4-hydroxynonenal, ethanol or artificial 
cerebrospinal fluid
5.4.1.1 Histology
In haematoxylin and eosin stained sections extensive tissue damage was observed 
extending rostrocaudally and medialolaterally away from the injection site in 4-HNE 
treated animals. There was evidence of tissue damage in both grey and white matter of 
the 4-HNE treated animals (Figures 5.3A & D). In the core of the lesion there was 
cellular and axonal loss within the subcortical white matter. In the adjacent grey matter, 
damaged neuronal perikarya appeared shrunken and eosinophilic. In contrast, in the 
vehicle, ethanol- and aCSF-treated animals the majority of neurons appeared 
morphologically unchanged (Figures 5.3B & E and Figures 5.3C & F) although, there 
was some evidence of damaged perikarya around the needle tract. There appeared to be 
some axonal damage in the subcortical white matter but this was restricted to the 
injection site in both ethanol and aCSF treated groups. Intracerebral injection of 4-HNE 
caused a significantly larger lesion compared to either ethanol or aCSF treated groups 
p<0.01 (Figure 5.4).
5.4.1.2 Axonal pathology
In the 4-HNE treated animals there was intense p-APP immunoreactivity across the 
subcortical white matter adjacent to the injection site. p-APP immunoreactive axons 
were also prominent within the genu of the corpus callosum and in the subcortical white 
matter of the contralateral hemisphere (Figure 5.5A). Medial to the injection site there 
was intense p-APP immunoreactivity in the subcortical white matter but in the adjacent 
grey matter neuronal perikarya appeared normal (Figure 5.5B). Ethanol treated animals 
did exhibit some p-APP immunopositive axons but this was confined to a region around 
the site of injection. A similar pattern of immunoreactivity was observed in the aCSF 
treated group (Figure 5.5C).
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Figure 5.3A Morphological changes in white m atter following
intracerebral injection of 4-hydroxynonenal, ethanol or artificial 
cerebrospinal fluid at high magnification
Haematoxylin and eosin histology in A) 4-HNE, B) ethanol and C) aCSF. There was 
extensive axonal damage observed in the subcortical white matter in the 4-HNE treated 
groups compared to the ethanol and aCSF treated groups. X400 Magnification.
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Figure 5.3B Morphological changes in grey and white matter following
intracerebral injection of 4-hydroxynonenal, ethanol or artificial 
cerebrospinal fluid at low magnification
Haematoxylin and eosin histology in D) 4-HNE, E) ethanol and F) aCSF. In the 
vehicle, treated group, the majority o f  neurons and axons appeared normal (arrows 
heads) with the exception o f  a few damaged neurons and axons around the needle tract. 
This type o f  pathology was also indicative in the aCSF treated group. In the 4-HNE 
treated animals there was shrinkage o f  neuronal perikarya (arrows) with extensive 
cellular and axonal loss within the subcortical white matter. X200 Magnification.
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Figure 5.4 4-hydroxynonenal induces brain damage (lesion volume)
There was a signifieant inerease in lesion volume o f the 4-HNE (n = 6) treated group 
compared to ethanol (n = 5) or CSF (n = 3) treated groups. There was no difference in 
lesion size between ethanol or CSF treated animals. Statistical analysis was performed 
using one way ANOVA and post tested with Student’s t test and corrected for 
Bonferroni. Data expressed as ± SEM * p <0.01.
99
Figure 5.5 (3-amyloid precursor protein immunohistochemical staining in the 
subcortical white matter following intracerebral injection of 
4-hydroxynonenal, ethanol or artificial cerebrospinal fluid
(3-APP immunostaining in A) 4-HNE, B) ethanol and C) aCSF treated animals. In the 4- 
HNE treated animals there was intense (3-APP accumulation around the injection site. 
These p-APP immunopositive bulbs and swellings were still evident in the subcortical 
white matter o f  the contralateral hemisphere. In contrast, in the control groups B) and C) 
there were relatively few p-APP immunoreactive axons and these were restricted to the 
injection site. Arrows indicate p-APP immunopositive axons. X400 Magnification.
5.4.1.3 Quantitative analysis of neuronal perikaryal damage and 
axonal injury
The extent o f neuronal perikaryal damage in grey matter was significantly greater in the 
4-HNE treated animals compared to the relatively small amount o f damage observed in 
the ethanol and aCSF treated animals. Quantitative analysis demonstrated an 
approximately 75% increase in the amount o f neuronal perikaryal damage in the 4- 
HNE treated group (Figure 5.6A). The amount o f  axonal injury in the subcortical white 
matter was approximately 85% greater in the 4-HNE treated group than in either o f  the 
ethanol or aCSF treated groups (Figure 5.6B). P-APP immunostained sections 
counterstained with haematoxylin from the 4-HNE treated group revealed that in an area 
away from the injection site where the neuronal perikarya appeared normal there was 
evidence o f p-APP immunopositive axons in the underlying white matter (Figure 5.7). 
Thus the data suggests that components o f white matter could be more vulnerable to 4- 
HNE than neuronal cell bodies.
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Figure 5.6 Extent of grey and white matter damage following intracerebral
injection of 4-hydroxynonenal, ethanol and artificial cerebrospinal fluid
The number o f grid points counted per mm2 in the 3 treated groups in A) grey matter 
and B) white matter. The data in A) 4-HNE demonstrated a significantly larger increase 
in the extent o f neuronal damage compared to ethanol or aCSF treated group. In B) the 
amount o f P-APP immunoreactive axons following intracerebral injection o f  4-HNE 
also demonstrated a significant increase in axonal damage compared to the ethanol or 
aCSF treated group. There is no difference in the area o f  neuronal or axonal damage 
between either the ethanol or aCSF treated groups. Data are mean + SEM, one way 
ANOVA post-tested with Student’s t test and corrected with Bonferroni.
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Figure 5.7 p-Amyloid precursor protein immunoreactivity following intracerebral 
injection of 4-hydroxynonenal
The scanned photograph shows a p-APP immunostained section from an 4-HNE treated 
animal. p-APP immunopositive axons in the subcortical white matter were prominent in 
4-HNE treated animals (arrows) whereas in the adjacent grey matter the neuronal 
perikarya appeared normal (arrow heads). X400 Magnification.
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5.4.1.4 Immunohistochemistry
4-HNE immunoreactivity was present in damaged neurons around the needle tract in all 
three treated groups. In contrast, in the subcortical white matter 4-HNE 
immunoreactivity was restricted to the site of injection in the 4-HNE and ethanol treated 
animals (Figure 5.8A and Figure 5.8B) but was absent from the subcortical white 
matter in the aCSF treated animals. However there was greater intensity of 4-HNE 
immunoreactivity in the 4-HNE treated group in contrast to the ethanol-treated group 
(Figure 5.8C).
Calpain-mediated spectrin breakdown products detected by the polyclonal antibody 
SBAbS2, detected pathological changes in the cortex in all three treated groups. 
SBAbS2 immunopositive neuronal perikarya were present in the cortex of the 4-HNE 
treated group (Figure 5.9A). However, in the ethanol and aCSF treated groups there was 
no evidence of immunopositive neuronal perikarya but there was an irregular rough 
appearance in the neuropil around the needle tract in these two groups. There was no 
evidence of calpain-mediated spectrin breakdown products within the subcortical white 
matter in any of the three treated groups (Figure 5.9B and Figure 5.9C).
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Figure 5.8 4-HNE-Michael adducts immunostaining following intracerebral
injection of 4-hydroxynonenal, ethanol or artificial cerebrospinal fluid
4-HNE immunostaining in A) 4-HNE, B) ethanol and C) 4-HNE treated animals. There 
were 4-HNE-Michael adducts present within the subcortical white matter in the 4-HNE 
and ethanol treated groups (arrows). There was no evidence o f  4-HNE 
immunoreactivity in the aCSF treated group. X400 Magnification.
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Figure 5.9 Calpain-mediated spectrin breakdown products immunostaining 
following intracerebral injection of 4-hydroxynonenal, ethanol or 
artificial cereberospinal fluid
The polyclonal antibody SBAbS2, detected calpain-mediated spectrin breakdown 
products in A) 4-HNE, B) ethanol and C) aCSF treated animals. In the ethanol- and 
aCSF-treated animals immunoreactivity had an irregular rough appearance around the 
injection site in the cortex. However, in the 4-HNE treated group neuronal perikarya in 
the cortex was immunopositive for calpain-mediated spectrin breakdown products 
positive. X400 Magnification
5.4.2 Effect of 4-hydroxynonenal in oligodendrocyte cultures
Exogenous 4-HNE induced both time and concentration dependent oligodendrocyte 
death in culture in vitro. There was microscopic evidence of oligodendrocyte cell death 
detected by trypan blue uptake within 1 hour at the lowest concentration, 1 pM 4-HNE. 
However after 4 hours incubation with the highest concentration, 50pM 4-HNE had 
killed all the oligodendrocytes in culture (Figure 5.10 and Figure 5.11). At this same 
time point concentration dependent changes in oligodendrocyte morphology were 
observed detected by the cytoskeletal protein, spectrin. In the vehicle, 0.2% ethanol and 
lpM  4-HNE treated cells, perikarya were preserved and oligodendrocyte processes 
showing spectrin immunoreactivity were evident. However, treatment with 10 or 50pM 
4-HNE caused fragmentation of processes and cell shrinkage (Figure 5.12).
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Figure 5.10 Exogenous 4-hydroxynonenal increased oligodendrocyte cell death in 
a time dependent manner
The percentage of oligodendrocyte cell death was increased at 1, 2 and 4 hours. There 
was 100% cell death after 4 hours at the highest concentration of 4-HNE.
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Figure 5.11 Exogenous 4-hydroxynonenal increased oligodendrocyte cell death in a 
concentration dependent manner
Percentage o f oligodendrocyte cell death is increased in a concnetration dependent 
manner. There was a significant increase produced in percentage cell death after 1 and 
lOpM 4-HNE incubation. The highest concentration 50pM 4-HNE produced 100% 
oligodendrocyte cell death after 4 hours incubation. Data are mean + SEM, one way 
ANOVA post-tested with Student’s t test and corrected with Bonferroni. *** p>0.001,
** p>00.1
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figure 5.12 Morphological changes observed in oligodendrocyte cultures
The antibody to cytoskeletal protein spectrin detected morphological changes in 
oligodendrocyte cultures incubated with A) 0.2% ethanol, B) lp M  4-HNE, C) lOpM 4- 
HNE and D) 50pM  4-HNE over a period o f  4 hours. X200 Magnification.
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5.4.3 Immunohistochemistry following permanent focal cerebral 
ischaemia
Neuronal pathology following 24 hours of cerebral ischaemia was demonstrated using 
haematoxylin and eosin staining. The ischaemic damage was confined to the 
hemisphere where the artery had been occluded. The amount and distribution of axonal 
damage reflected by the accumulation of P-APP was widespread within the ischaemic 
lesion. Neuronal and axonal damage demonstrated characteristic patterns of pathology 
observed after permanent focal cerebral ischaemia in the rat. 4-HNE-Micheal adducts 
were evident in neuronal perikarya, axons and glial cells within the infarcted region. 
The distribution of 4-HNE immunopositive axons (Figure 5.13B) in the ischaemic 
hemisphere was identical to that of p-APP accumulation in axons observed in adjacent 
sections (Figure 5.13A). 4-HNE immunoreactive neurons marked a defined boundary 
between ischaemic and normal tissue in the cortex (Figure 5.13C). There was no 4- 
HNE-Michael adducts or p-APP immunoreactivity present in the contralateral 
hemisphere.
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Figure 5.12 Morphological changes observed in oligodendrocyte culture*}
The antibody to cytoskeletal protein spectrin detected morphological changes in 
oligodendrocyte cultures incubated with A) 0.2% ethanol, B) lpM  4-HNE, C) lOpM 4- 
HNE and D) 50pM  4-HNE over a period o f  4 hours. X200 Magnification.
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Figure 5.13 Immunostaining of 4-HNE-Michael adducts and p-APP
accumulation following 24 hours permanent focal cerebral ischaemia
A) p-APP accumulation in axons within the ischaemic lesion B) 4-HNE-Michael 
adducts immunoreactivity in myelinated axons and C) cerebral cortex. 4-HNE-Micheal 
adducts paralleled the pattern o f  p-APP accumulation in axons. In the cerebral cortex 4- 
HNE immunopositive neurons marked a clear boundary (dotted line) tissue showing 
evidence o f  ischaemic damage and that with a normal appearance. X400 Magnification.
5.5 DISCUSSION
Intracerebral injection of 4-HNE caused extensive cellular and axonal damage within 
the subcortical white matter in vivo. A previous study induced neuronal perikaryal 
damage following injection of a 10 fold higher concentration of 4-HNE into the basal 
forebrain (Bruce-Keller et alv 1998). However, in the present study, a 10 fold lower 
concentration of 4-HNE injected into the subcortical white matter caused damage to 
both neuronal perikaryal and myelinated axons. Axonal damage, detected by the P-APP 
accumulation, was observed transversing medially and laterally along the subcortical 
white matter away from the injection site. Within the core of the lesion, P-APP 
accumulation was intense across the depth of the subcortical white matter and 
immunopositive swellings and bulbs were also evident in the subcortical white matter in 
the contralateral hemisphere to the injection site. In contrast, in the ethanol- or aCSF- 
treated animals there were relatively minor pathological changes within axons and these 
were restricted to an area immediate to the injection site. Shrunken neuronal perikarya, 
detected by conventional histology, in the adjacent grey matter were present in all 
animals from the 4-HNE ethanol and aCSF treated groups. However, neuronal damage 
extended further away from the injection site in the 4-HNE treated group whereas it was 
confined to a small region around the needle tract in the ethanol and aCSF treated 
groups. It has been suggested that 4-HNE causes damage to neuronal perikarya by 
binding to microtubules, microtubule associated proteins and neurofilaments (Montine 
et al., 1996a; Mattson et al., 1997; Neely et al., 1999). In axons these proteins are 
essential for both structural stability and transportation mechanisms. Therefore, in axons 
4-HNE induced injury may also be mediated by damage to these cytoskeletal proteins. 
Conformational changes in p-tubulin located in synaptosomes were induced by 
exposure to 4-HNE (Subramaniam et al., 1997) and p-tubulin is an essential component 
of microtubules which are responsible for axonal transport. Thus, conformational 
changes in axonal p-tubulin by 4-HNE may cause cessation of axonal transport which is 
reflected by the accumulation of p-APP. In patients who died after a head injury there 
was accumulation of P-APP in axons, however there was no change in the protein levels 
of p-tubulin compared to control patients (see Chapter III). Although, at present it is 
not known if 4-HNE levels are increased in the human brain after head injury, it might 
be speculated that 4-HNE induced damage of p-tubulin is involved in the process of 
axonal damage.
I l l
Following intracerebral injection of 4-HNE preserved neuronal perikarya were present 
in grey matter overlying the subcortical white matter in which there was p-APP 
immunoreactive axons. This suggests that pathological changes in the myelinated axons 
are independent of neuronal cell body damage. The extent of white matter pathology in 
the 4-HNE treated animals compared to controls could be due to the exogenously 
administered 4-HNE initiating a process of reactive changes within axons. 4-HNE itself, 
could initiate lipid peroxidation and the large quantity of lipids within myelinated axons 
could increase their susceptibility to this self propagating process. This process could 
account for the spread of axonal pathology observed away from the initial injection site.
4-HNE-Michael adducts were detected in neuronal and glial cells but not in axons 
following intracerebral injection of 4-HNE and this immunostaining was restricted to a 
small area around the injection site. In the ethanol treated group a similar pattern of 
immunostaining was observed to that seen in the 4-HNE treated group. In contrast, in 
the aCSF treated animals there was no 4-HNE immunostaining in the subcortical white 
matter and only a few 4-HNE immunopositive neuronal perikarya were observed 
adjacent to the needle tract in the cortex. p-APP accumulation within myelinated axons 
was observed distant from the injection site although there were no 4-HNE-Michael 
adducts present in the same region. However, this does not necessarily mean that the 
toxic properties of 4-HNE were not involved in the production of axonal pathology. 
Exogenous 4-HNE may initiate secondary mechanisms of damage and these are 
discussed further below. 4-HNE can form either Michael or pyrolle adducts and the 
antibodies used in the present study detect only the former one. A comparative study in 
Alzheimer’s disease brain tissue demonstrated that antibodies against 4-HNE Michael 
or pyrolle adducts have distinct patterns of immunoreactivity (Montine et al., 1998). In 
the present study, the presence of pyrolle adducts was not determined and it is possible 
that these also exist after intracerebral injection of 4-HNE. This may explain the 
disparity between the extent of 4-HNE-Michael adducts immunoreactivity and that of 
axonal pathology.
Secondary pathologic mechanisms may be induced by exogenously injected 4-HNE 
initiating elevation of intracellular Ca2+ and subsequent activation of calpains. 4-HNE 
inhibits the Na+K+-ATPase transporter by either reducing ATP, via mitochondrial
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dysfunction (Keller et al, 1997; Picklo et al., 1999), or by directly binding to the ionic 
transporter (Siems et al., 1996; Mark et al., 1997). Inhibition of the Na+K+ATPase 
transporter could cause disturbances of Ca2+ homeostasis and increases of intracellular 
Ca levels. Calpain-mediated spectrin breakdown products were present in grey 
matter adjacent to the injection site in all the 4-HNE- ethanol- and aCSF-treated groups. 
This immunoreactivity appeared as a diffuse staining localised mainly in the neuropil. 
However, calpain-mediated spectrin breakdown products were present in neuronal cells 
only in the 4-HNE treated group but not in controls. There was no evidence of calpain- 
mediated spectrin breakdown products within myelinated axons in any of the treated 
groups. Calpain immunopositive oligodendrocyte-like cells were present in the 4-HNE 
treated group but these cells were also present in the ethanol and aCSF treated group. 
Therefore, these findings do not support a role for calpain-mediated damage as a 
secondary pathogenic mechanism in white matter after intracerebral injection of 4-HNE.
Histological and immunohistochemical analysis of the tissue following 4-HNE injection 
readily detected pathological changes in neurons and axons. However, these methods 
did not reveal marked changes in oligodendrocytes, which may have indicated a direct 
toxic effect of 4-HNE on these cells. In addition, damage to white matter 
oligodendrocytes could be secondary to changes in their microenvironment resulting 
from damage to adjacent axons or astrocytes. Oligodendrocyte vulnerability secondary 
to changes in the microenvironment has been proposed to be predominately due to 
alterations in astrocytic function. 4-HNE crosslinks to the GLT 1 glutamate uptake 
transporter (Springer et al., 1997; Keller et al., 1997; Blanc et al., 1998) and inhibition 
of this transporter could render adjacent cells vulnerable to excitotoxicity. Li et al., 1999 
have demonstrated in a model of spinal cord injury and in vitro anoxia that there was an 
efflux in glutamate from axonal cylinders and possibly oligodendrocytes. The rise in 
extracellular glutamate probably occurs as a result of membrane depolarisation and 
reversal of the Na+-dependent glutamate transporter. Therefore, excess glutamate into 
restricted spaces could damage axons and oligodendrocytes. Oligodendrocytes are 
extremely vulnerable to glutamate toxicity via AMPA (a-amino-3-hydroxy-5-methyl-4- 
isoxate propionic acid) or kainate receptors (McDonald et al., 1998). Cell culture was 
used in the present study to provide an isolated situation to assess whether 4-HNE had a 
direct effect on oligodendrocytes rather than secondary induced mechanisms involving
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axons and other glial cells. Exogenous 4-HNE was also toxic to oligodendrocytes in 
culture in vitro. Oligodendrocyte cell death was both time and concentration dependent 
with maximum cell death following 4 hours exposure to the highest concentration, 
50pM 4-HNE. At the lowest concentration there was evidence of oligodendrocyte cell 
death after 1 hour exposure to lpM  4-HNE. The percentage of oligodendrocyte cell 
death after treatment with 10 or 50pM 4-HNE also increased with incubation time.
Morphological alterations of these cells were detected by changes in 
immunohistochemistry of the cytoskeletal protein, spectrin. After treatment with either 
vehicle (0.2% ethanol) or 1 pM 4-HNE, oligodendrocyte perikarya were preserved and 
processes emanating from the cell body were clearly evident. After exposure to 10 or 
50pM 4-HNE, oligodendrocyte cell bodies were shrunken and their processes were 
fragmented. This study demonstrates that 4-HNE has a direct toxic effect on 
oligodendrocytes. Taken together the in vivo and in vitro data indicate that exogenously 
administered 4-HNE is toxic to both axons and oligodendrocytes. However, if this toxin 
by-product is to be implicated as a pathogenic factor in acute brain injury, it is necessary 
to demonstrate that the levels of endogenous 4-HNE are elevated in response to acute 
brain injury.
To address this issue the presence or absence of 4-HNE-Michael adducts were 
determined in an experimental model of acute brain injury, permanent focal cerebral 
ischaemia in the rat. Conventional histology revealed pyknotic neurons and 
morphological characteristics of ischaemic brain damage in the cortex and striatum of 
the cerebral hemisphere where the middle cerebral artery had been occluded. 
Endogenous 4-HNE detected by immunohistochemistry was present in neurons, axons 
and glia cells within the area of ischaemic damage. 4-HNE-Michael adducts were 
present in necrotic neurons particularly at the boundary between ischaemic and normal 
tissue in the cerebral cortex. There was widespread axonal injury within the ischaemic 
striatum detected by p-APP accumulation. 4-HNE-Michael adducts revealed 
immunostaining within ischaemic axons and the staining pattern paralleled the pattern 
of axonal p-APP accumulation. 4-HNE modified proteins were demonstrated in 
experimental traumatic brain injury (Zhang et al., 1999), a model of transient cerebral 
ischaemia in rats (Urabe et al., 1998) and global ischaemia in apolipoprotein E (apoE)
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knockout mice. In this latter model, intraventricular infusion of apoE reduced both 
ischaemic neuronal and 4-HNE immunoreactivity (Horsburgh et al,. unpublished data). 
ApoE has been proposed as an antioxidant (Miyata and Smith 1996). This data suggests 
that there is an interaction between endogenous 4-HNE and oxidative stress. Oxidative 
stress and 4-HNE have been implicated as a major factor involved in the pathogenesis 
of the chronic neurodegenerative condition, Alzheimer’s disease (Montine et al., 1997a; 
Montine et al., 1997b; Lovell et al., 1997; see review Mattson and Pedersen 1998). 
Therefore, 4-HNE toxicity may play a role in both acute and chronic degenerative 
conditions.
In summary, exogenous 4-HNE was toxic to both axons and neurons in vivo and to 
oligodendrocytes in culture in vitro. In addition, endogenous levels of 4-HNE were 
increased in axons, neurons and glia after acute brain injury induced by ischaemia. 
Therefore, the results suggest that 4-HNE induced damage may constitute a common 
pathologic mechanism in both grey and white matter following acute brain injury.
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CHAPTERVI 
GENERAL DISCUSSION
6.1 GENERAL DISCUSSION
6.1.1 Pathogenic mechanisms in white matter
The data produced within this thesis provide substantial evidence to support the 
hypothesis that myelinated axons and oligodendrocytes, components of white matter, 
are susceptible to multiple pathogenic mechanisms following acute brain injury. These 
include calpain-mediated breakdown of the cytoskeleton, oxidative stress and lipid 
peroxidation.
In human head injury there was degradation of axonal cytoskeletal proteins and 
evidence of calpain activation in the corpus callosum, a white matter commissure, 
where axonal damage is frequently observed following head injury (Adams et al., 1989; 
McKenzie et al., 1996). Although, there is evidence suggesting a role for calpain- 
mediated damage in experimental models of traumatic brain injury (TBI) the results 
from this study demonstrate that calpain-mediated proteolysis has a direct role in 
producing axonal damage in the clinical condition. Axonal damage was present in 
patients with the characteristic pathology of diffuse axonal injury (DAI) or ischaemia. 
This suggets that blunt head injury could prompt different pathogenic mechanisms that 
are involved in axonal damage.
Axonal injury was produced following systemic injection of the mitochondrial inhibitor,
3-nitropropionic acid in the rat. There was a concentration dependent increase in the 
amount and distribution of axonal pathology. The correlation between P-APP 
accumulation and calpain-mediated spectrin breakdown products in head-injured 
patients was not present in this experimental animal model. Calpain-mediated 
proteolysis only detected cytoskeletal changes in oligodendrocyte-like cells within the 
subcortical white matter. Increased Mn-SOD immunoreactivity within the striatum 
supports a role for oxidative stress mediating axonal injury. However, this experimental 
model of oxidative stress could increase the amount of calpain activation via increased 
intracellular calcium (Dykens 1994; Desphande et al., 1997; Silver and Ercinska 1990). 
Calpain activation stimulates production of free radicals through irreversible conversion 
of xanthine dehydrogenase to xanthine oxidase (Fridovich 1970; McCord 1985;
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Sussman and Bulky 1990). This suggests that at least two pathogenic mechanisms could 
be working alone or in alliance mediating damage in axons and oligodendrocytes.
Intracerebral injection of the lipid peroxidation cytotoxic by-product, 4-HNE into the 
subcortical white matter of rats produced damage in myelinated axons. The distribution 
of axonal pathology did not appear to be associated with endogenous 4-HNE or calpain- 
mediated damage. Thus, suggesting that exogenous 4-HNE could be inducing secondary 
pathogenic mechanisms other than lipid peroxidation or calpains that are responsible for 
axonal damage observed away from the injection site. Cytoskeletal protein changes and 
cell death were observed in cultured oligodendrocytes after administration of exogenous 
4-HNE. To investigate if 4-HNE induced oligodendrocyte cell death was coupled to 
calpain activation, an experimental paradigm could be devised which would determine 
the protein levels of calpain-mediated spectrin breakdown products in oligodendrocyte 
cultures by means of Western blotting. Endogenous 4-HNE modifed proteins were 
present within damaged axons and glia cells after permanent cerebral ischaemia in the 
rat. The results in these studies demonstrate that axons and oligodendrocytes are 
vulnerable to the pathogenic mechanisms calpains, oxidative stress and lipid 
peroxidation.
In the past white matter damage was thought to be secondary to neuronal necrosis after 
cerebral ischaemia (Marcoux et al., 1982). Axonal and oligodendrocyte damage was 
observed within 1 hour following cerebral ischaemia preceding neuronal necrosis (Yam 
et al., 1998b; Pantoni et al., 1996). DAI is a primary pathological occurrence observed 
after head injury. It was once perceived that DAI occurred as a result of the initial 
traumatic injury (Povlishock and Christman 1995; Gennarelli 1997). However, it is now 
recognised that many axons undergo secondary delayed damage. (Graham and 
Gennarelli 1997; Maxwell et al., 1997). However, the data from this thesis highlights 
the vulnerability of axons and oligodendrocytes to secondary pathogenic mechanisms 
that could be triggered after acute brain injury. The axonal cytoarchitecture provides a 
pathway for transportation of protein organelles along the axon. Damage to these 
cytoskeletal proteins could result in disruption of the unique structural arrangement and 
cessation of axonal transport. Although this thesis has focused on white matter injury it 
is important not to forget the rest of the neuron. Perikaryal damage along side a
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protected axon could still lead to brain dysfunction as the cell body is the source of 
protein synthesis.
The experimental animal model of oxidative stress used in this thesis demonstrated 
neuronal perikaryal damage within the striatum. The amount and distribution of 
neuronal damage was not present in any of the 3-NPA concentrations before 
accumulation of p-APP or SNAP-25 was observed. Although this model does not 
distinguish between neurons and axons it does suggest that axonal injury could be 
independent of neuronal damage. To decipher whether axons themselves were 
vulnerable to this toxin, 3-NPA could be injected into the subcortical white matter and 
the extent of axonal damage measured by the same endpoints as was used in Chapter V. 
Following intracerebral injection, damaged perikarya were observed in the adjacent 
grey matter next to the injection site. The amount of neuronal damage was greater in the
4-HNE-treated compared to the control groups. This data demonstrates that both 
neurons and axons are vulnerable to pathogenic mediators, whether these are primary or 
secondary mechanisms, it does provide a link between grey and white matter damage.
6.1.2 Common pathological mechanisms in grey and white matter
There is compelling evidence supporting a role for calpain-mediated damage in grey 
matter in experimental animal models of stroke and TBI. The breakdown of 
cytoskeletal proteins and increased calpain-mediated spectrin breakdown products in 
grey matter have been demonstrated in models of traumatic (Posmantur et al., 1994; 
Kampfl et al., 1996; Saatman et al., 1996; Fitzpatrick et al., 1997) and ischaemic 
(Inzuka et al, 1990; Hong et al., 1994; Roberts-Lewis et al.,1994; Bartus et al., 1995; 
Pettigrew et al., 1996) brain injury. However, in the literature there is not as much 
evidence for cytoskeletal breakdown with concomitant increase in calpain-mediated 
proteolysis in white matter after traumatic (Saatman et al., 1996a; Fitzpatrick et al.,
1997) or ischaemic (Dewar and Dawson 1996) brain injury compared to grey matter. 
Damage to neuronal perikarya and axons after acute brain injury are likely to contribute 
to behavioural dysfunction after acute brain injury. Calpain inhibitors have been 
reported as potential therapeutic agents for treatment of acute brain injury. In models of 
experimental TBI administration of calpain inhibitors attenuated cytoskeletal 
breakdown and calpain-mediated spectrin breakdown products (Saatman et al., 1996b;
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Posmantur et al., 1997). The amount of ischaemic damage can be reduced by a calpain 
inhibitor (Takagaki et al., 1997) even when administration is delayed for up to six hours 
after induction of ischaemia (Markgraf et al., 1998). Banik et al., (1997b) demonstrated 
protection of the myelinated fibre tracts after spinal cord injury. Combination therapy, 
where a calpain I inhibitor and methylprednisolone, (an anti-inflammatory and free 
radical inhibitor), prevented neurofilament breakdown in the spinal cord (Banik et al.,
1998). Therefore, suggesting that calpain inhibition could prove successful in protecting 
the neuronal perikarya and the axonal cytoskeleton after acute brain injury.
The axonal cytoskeleton is vulnerable to oxidative stress detected by the accumulation 
of the axonal transport proteins p-APP and SNAP-25 following systemic injection of 3- 
NPA. Oxidative stress has been implicated as a major pathogenic factor in neuronal 
perikaryal damage (see reviews Flamm et al., 1978; Chan 1994; Doopenberg et al., 
1998; Murphy et al., 1999; Love 1999). Thus representing another common mechanism 
between grey and white matter damage. The introduction of transgenic mice has led to a 
great deal of research investigating the role of endogenous antioxidants. The size of 
infarction was increased in Mn-SOD knockout mice (Murakami et al., 1998) while 
Cu/Zn SOD knockout mice demonstrated enhanced neuronal perikaryal and axonal 
damage (Reaume et al,. 1996) compared to their wildtypes, further supporting a role for 
oxidative stress as a pathogenic link between grey and white matter. Transgenic mice 
can also be used to investigate the role of neuroprotection. Mice overexpressing the 
cytosolic Cu/Zn SOD enzyme demonstrated a reduction in infarct volume in models of 
reperfusion and experimental TBI (Kinouchi et al., 1991; Yang et al., 1994; Mikawa et 
al, 1996) but not following permanent ischaemia (Chan 1993). Therefore accumulation 
of free radicals, which occurs after acute brain injury and the relative paucity of 
endogenous antioxidants in the brain (Coyle and Puttfarcken 1993) could contribute to 
the neuronal and axonal damage. The failure of overexpressed Cu/Zn SOD mice to 
protect against neuronal damage following permanent cerebral ischaemia suggests that 
different mechanisms could be involved depending on the type of insult. Although 
these animal studies look encouraging, antioxidants are hydrophilic and cannot cross the 
blood brain barrier (BBB). In a previous study, addition of vitamin E failed to protect 
against global ischaemia (Clemens and Panetta 1994). However, the addition of a 
lipophilic triphyenlphosphonium cation, allowed the compound to cross the BBB and
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increase the half life of the enzyme. Entry of this compound into the mitochondria 
induced an 80 fold increase in the pool of antioxidants available (Smith et al., 1999). 
The lipophilic polyethylene glycol conjugated to SOD increased functional outcome in 
head-injured patients (Muizellar et al., 1993). Increase SOD activity leads to elevated 
tissue levels of hydrogen peroxide. If there is not a compensatory increase in catalase or 
glutathione peroxidase (GPx) then hydrogen peroxide will be converted to the potent 
hydroxyl radical which can initiate a continuous cascade of oxidative stress.
Tirilazad mesylate, a 21 aminosteroid compound is member of the antioxidant family, 
the Lazeroids. Tirilazad is lipid soluble and inhibits lipid peroxidation (Braughler et al., 
1989b). However, at concentrations administrated during a phase II clinical trial the 
drug appeared to be unsafe (Marshall and Marshall 1995). A lipid peroxidation inhibitor 
pyrrolopyrindine U101033E, penetrates the BBB restoring function in the electron 
transport chain, energy coupling and ion homeostasis after trauma (Xiong et al., 1997) 
and reduced infarct volume after cerebral ischaemia (Oostveen et al., 1998). This type 
of therapeutic agent could also be beneficial following acute brain injury as it prevents 
pathogenic mediators that have been shown to induce neuronal perikarya and axonal 
damage. Combinational therapy of a Lazaroid and pyrrolopyrimdine reduced total 
infarct volume by over 50% (Schmid-Elsasser et al., 1999). This result also suggests 
that more than one mechanism could be involved in the pathogenesis of brain injury as 
the results in this thesis have demonstrated.
The spin trap agent, PBN (a-phenyl-tert-butyl-nitrone) reacts with free radicals 
resulting in the formation of the stable nitroxide radical adducts. PBN has been 
previously demonstrated to reduce neuronal damage following permanent cerebral 
ischaemia (Cao and Phillis 1994). Increased immunoreactivity of the cytoskeletal 
protein tau was present in oligodendrocytes after human head injury and stroke (Irving
1996). PBN administration reduced these tau positive oligodendrocytes after permanent 
ischaemia in the rat at the same concentration that reduced neuronal damage (Irving et 
al., 1997). In contrast, administration of the NMDA antagonist and the AMPA 
antagonist, NBQX (2,3-dihydroxy-6-nitro7-sulfamylbenzo(f)quinoxaline) at 
concentrations known to be neuroprotective failed to reduce the number of tau positive
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oligodendrocytes. The interaction of glutamate as a secondary mechanism will be 
discussed below.
Ebselen (2-phenyl- l-2-benzioselenazol-3-2H(ene)) acts as a glutathione peroxidase 
(GPx) mimic reducing hydrogen peroxide to water; detoxifying lipid hydroperoxides; 
preventing arachadonic acid metabolism and inducing anti-inflammatory responses 
(Schewe 1995). Ebselen administration reduced total infarct volume in animal models 
of transient (Dawson et al., 1995) and permanent cerebral ischaemia (Takasgo et al.,
1997). Phase III clinical trials showed efficacy and safety of the drug (Yamaguchi et al.,
1998). This type of therapeutic agent could be beneficial in the treatment of acute brain 
injury as it scavanges elements of oxidative stress, lipid peroxidation and inflammation.
The data produced in this thesis demonstrated that there is a differential response 
between axons and oligodendrocytes to different pathogenic mechanisms. The literature 
also demonstrates that neuronal damage following acute brain injury can be reduced by 
a number of therapeutic agents targeting different pathologic mediators. The 
pathophysiology of acute brain injury is probably more multifaceted than previously 
thought. The main theme of this thesis has concentrated on white matter damage 
induced by non-receptor mediated mechanisms. However, the excitotoxin glutamate 
cannot be eliminated when discussing pathogenic factors in acute brain injury. 
Glutamate excitotoxicity is an important trigger in the pathogenesis of neuronal 
perikaryal death (Rothman and Olney 1986; Choi 1988). Although myelinated axons 
and oligodendrocytes do not possess NMDA receptors, AMPA and kainate receptors 
are located on oligodendrocytes (Patneau et al.,1994; Gallo and Russell 1995). 
Recently, it has been demonstrated that AMPA or kaniate receptor activation could 
mediate damage in axons after ischaemia and anoxia (Agrawal and Fehlings 1997; Li et 
al., 1999). The importance of glutamate induced toxicity is not just receptor activation 
but the biochemical cascade that it could initiate. Glutamate can induce oxidative stress 
in oligodendrocytes by depleting the glutamate-cysteine exchanger (Oka et al., 1993) or 
through mitochondrial inhibition (Lafon-Cazal et al., 1993; Dugan et al., 1993). 
Glutamate can also directly damage oligodendrocytes by binding to AMPA or kainate 
receptors (McDonald et al., 1998a 1998b). Oxidative stress can also increase 
extracellular glutamate through the lipid peroxidation aldeyhde, 4-HNE which binds to 
the GLT 1 transporter on astrocytes (Springer et al., 1997; Keller et al.,1997; Blanc et
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al.,1998). Calcium also works in an interactive process with glutamate. Firstly, through 
membrane depolarisation induces rapid Ca2+ influx and glutamate neurotransmitter 
release and from terminal synapses. Secondly, continuous activation of the NMDA 
receptor allows leakage of Ca2+ into the cell (see review Kristian et al., 1998). This 
evidence demonstrates the importance of glutamate and its ability to either directly 
cause white matter damage or through induction of secondary mechanisms that have 
been shown to cause axonal damage.
In summary, the hypothesised biochemical cascade between metabolic dysfunction, 
oxidative stress, lipid peroxidation, calcium and glutamate could all contribute to 
damage in neuronal perikaryal, myelinated axons and glial cells (Figure 6.1). The brain 
is a complex organ that has multiple neuronal-axonal; neuronal-glia; axonal-glia and 
glia-glia interactions that may all depend on each other. The complex interaction 
between one and more of the above pathogenic mediators could account for the varied 
susceptibility of cellular and axonal damage observed after acute brain injury. The 
mechanistic pathway could depend on whether the injury is traumatic or ischaemic, 
primary or secondary and whether the damage is diffuse or focal, emphasising the 
complexity of the pathophysiology that occurs after acute brain injury. The type of 
damage and the pathway to that damage also depends on the surrounding 
microenvironment.
The hypothesis of secondary damage is a complex phenomenon. However, it could 
provide multiple targets for therapeutic intervention. In the past, clinical intervention 
was targeted towards salvaging the neuronal perikarya via a single mechanism. 
However, these therapeutic agents did not prove successful in clinical trials of acute 
brain injury (Dyker and Lees 1998). It could be speculated that these drugs did not 
work, as they did not protect axonal damage. Therefore, it is important to protect the 
whole neuron and not a specific component. Neuronal perikaryal produces cellular 
information, axons provide the circuitry pathway for this information and synapses 
allow information to be transmitted from one neuron to another. Therefore because of 
the combined complexity of brain anatomy and pathogenic mediators, discerning the 
molecular mechanism involved requires further investigation to gain a comprehensive 
understanding of the pathophysiology that occurs following acute brain injury.
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Figure 6.1 Biochemical cascade of primary and secondary mechanisms after acute 
brain injury
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APPENDICES
APPENDIX 1
Suppliers of commonly used chemicals
ABC Vector
Alkaline phosphatase substrate kit Bio-Rad
Anit-mouse IgG HRP Promega
Anti-rabbit IgG HRP Promega
Ammonium persulphate Sigma
Bovine pancreas DNAse Sigma
Bovine serum albumin, fraction V GIB CO
BSA path-o-cyte 4 GIB CO
Collagenase Sigma
DAB Vector
DMEM GIBCO
ECL Amersham
Gentamycin GIBCO
Glutamine GIBCO
Hydrogen peroxide Sigma
4-hydroxynonenal Cayman chemicals
4-hydroxynonenal-Michael adducts Calbiochem
HBSS GIBCO
3-nitropropionic acid Sigma
PBS Oxoid
Protogel National Diagnostics
Progesterone Sigma
Putrescine Sigma
SDS Bio-rad
Sodium selenite Sigma
Soya bean trypsin inhibitor Sigma
Streptavidin-alkaline phosphatase Amersham
TEMED Sigma
Thyroxine T4 Sigma
Tris Sigma
Tri-iodo-thryonine T3 Sigma
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APPENDIX 2 Stock solutions
CELL CULUTRE 
Sato’s media
(0.029pl BSA path-o-cyte4 PBS;1.61mg/ml putrescine/H20;
0.4mg/ml thyroxine T4/EtOH; 0.34mg/ml tri-iodo-thryonine T3/etoh ; 0.62mg/ml
progesterone/EtOH and 0.387mg/ml sodium selenite/etoh Sato’s mix is asecptically 
filtered (0.22pm).
Soya bean trypsin-DNAse inhibitor
(0.52mg/ml soya bean trypsin inhibitor, 0.04mg/ml bovine pancreas DNAse 
3.0mg/ml bovine serum albumin, fraction V)
20% fetal calf serum in DMEM
20% fetal calf serum; Dulbecco’s Modified Eagles Medium;
200mM glutamine and 25pg/ml gentamycin
WESTERN BLOTTING
Table A. 1 Composition of SDS-PAGE gels
12.5% 
resolving gel
10% resolving 
gel
8% resolving 
gel
H20 8.6 ml 13.2 ml H20 45.6 ml
1.5M tris 12 12 Prosieve 12.8
Protogel 23 18.4 1.5 M Tris 20
Glycerol 50% 4 4 SDS 10% 0.8
APS 10% 0.32 0.32 APS 10% 0.8
TEMED 0.10 0.10 TEMED 0.04
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APPENDIX 3
Figure A1 Morphological changes in the striatum following systemic injection 
of 3-nitropropionic acid
Histological changes in the striatum following systemic injection o f  A) lOmg/kg B) 
15mg/kg and C) 20mg/kg 3-nitropropionic acid.
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AB
C
Figure A2 (3-Amyloid precursor protein immunostaining within myelinated fibre 
tracts following systemic injection of 3-nitropropionic acid
(3-APP accumulation within the myelinated fibre tracts o f the striatum following 
systemic injection o f  A) lOmg/kg, B) 15mg/kg and C) 20mg/kg 3-nitropropionic acid.
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Figure A3 SNAP-25 immunohistochemical staining following systemic injection of
3-nitropropionic acid
SNAP-25 immunoreactivity in the myelinated fibre tracts o f  the striatum following A) 
lOmg/kg, B) 15mg/kg and C) 20mg/kg 3-nitropropionic acid.
AB
C
Figure A4 Immunohistochemical staining of calpain-mediated spectrin
breakdown products in the subcortical white m atter following 
systemic injection of 3-nitropropionic acid
The number o f  SBAbS2 immunopositive oligodendrocyte-like cells following 
increased administration o f  A)10mg/kg, B) 15mg/kg and C) 20mg/kg 3-NPA
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Figure A5 Manganese superoxide dismutase immunohistochemical staining
following systemic injection of 3-nitropropionic acid
Increased cellular staining o f Mn-SOD in the striatum following systemic injection o f 
A)10mg/kg, B)15mg/kg and C) 20mg/kg 3-nitropropionic acid
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